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 ABSTRACT 
 
Determination of Cholesterol in Foods by Flow Injection Analysis with Perroxyoxalate 
Chemiluminescence  
 
by 
Abisake Feleke 
 
Cholesterol is an important biological molecule with many important functions.  
However, high serum cholesterol is a health hazard.  Thus analysis of cholesterol is 
important and many analytical techniques have been developed.  The objectives of the 
proposed research are to develop an economical, rapid method for the determination of 
total cholesterol with good selectivity and enhanced sensitivity.  For evaluation of 
proposed flow injection analysis with peroxyoxalate chemiluminescence (FIA-POCL) 
method, figures of merit such as accuracy, precision, and linear dynamic range will be 
assessed.  The proposed procedure was then applied to the determination of total 
cholesterol in foods.  The procedure was linear for cholesterol from 0.01 to 0.120 mg/mL.  
The relative standard deviation was 2.57 %.  The recoveries were 97.5 – 103.3 % for 
commercial standard cholesterol sample, and 101.5 – 108.0 % for butter.  The proposed 
method was applied to analysis of cholesterol in food and the results were consistent with 
expected values.  
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CHAPTER 1 
INTRODUCTION 
 
Cholesterol (cholest-5-en-3ß-ol), a fat like substance, with a polar secondary 
hydroxyl head group at the C3 position in the non-polar hydrocarbon body, is the major 
steroid in animal tissue.  Cholesterol is an important steroid and it is a common 
component of the membranes of animal cells.   It is synthesized in many types of tissue 
but particularly in the liver and intestinal wall.  Cholesterol is formed from squalene via 
lanosterol. [1, 2]   Its structure is shown in Figure 1.  
 
 
Figure 1. Chemical Structure of Cholesterol (C27H46O) 
 
Cholesterol is present in the free and esterified cholesterol forms.  However, there 
is no significant difference between the free and the esterified form of cholesterol other 
than the fact that in the case of the esterified form the cholesterol has a fatty acid attached 
to the hydroxyl group through the ester linkage. [1, 2] 
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Cholesterol is an essential molecule in many animals, including humans.  It is not 
required in the mammalian diet however, because all cells can synthesize it from simple 
precursors.  Moreover, cholesterol is important for the metabolism and transport of fatty 
acids and in the production of hormones and Vitamin D. [2, 3]  Cholesterol gives our 
cells the strength they need to maintain their shape.  Furthermore, it is essential for the 
formation and maintenance of cell membranes, which help the cells to resist changes in 
temperature, to protect and insulate nerve fibers.  In addition to its roles in the structure 
and function of membrane, cholesterol has another extremely important function.  
Cholesterol is the basic building block of the steroid hormones that are stored in the 
adrenal glands, testes, and ovaries where they are available whenever there is a need. The 
major groups of the steroid hormones include the male and female sex hormones. [2]    
Cholesterol is found in the blood stream and body cells.  It comes from two main sources.  
Cholesterol is ingested whenever animal product such as egg yolks, meat, fish, and dairy 
products are consumed by us.  Cholesterol helps to develop cellular and tissue membrane 
and is stored in organs and tissues of the body.  Cholesterol is also obtained from foods 
having saturated fatty acids or animal fat.  The liver is the secondary source of 
cholesterol.  Livers produce various amounts of cholesterol up to about 1,000 mg a day. 
[3-4]  Our bodies produce three to four times more cholesterol than what we get from our 
diet; therefore, about 80 % of the cholesterol is made by the liver.  Normally, the total 
amount of cholesterol from these two sources remains constant because the rate of 
cholesterol synthesis in the liver is under feedback control.  When the dietary intake is 
high, liver synthesis of cholesterol is low; and when intake is low, synthesis of 
cholesterol increases.  Naturally, cholesterol is manufactured by the liver and located in 
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cell walls, but it is also created by cells lining the small intestine and by individual cells 
in the body.  Lipoproteins, a combination of lipids (fats) and proteins, are made in the 
liver and carry cholesterol, fats, fat-soluble vitamins, and other lipids, to different parts of 
the body that requires energy production and any repair. [3, 4, 5] 
Bile salts such as taurocholic acid are also synthesized from cholesterol in the 
liver.  The synthesis of bile acid is one of the predominant mechanisms for the extraction 
of excess cholesterol from the body.  Bile acid is stored in the gallbladder and released 
into the small intestine after ingestion of fatty foods.  It acts as a biological detergent with 
four physiological functions, elimination of excess cholesterol, facilitating the digestion 
of dietary triacylglycerols by acting as emulsifying agents rendering access to pancreatic 
lipases, and solubilizing the cholesterol as well as facilitating the intestinal absorption of 
fat-soluble vitamins.  However, high cholesterol concentration in the bile may lead to 
gallstone formation. [2, 3] 
Excessive cholesterol in the blood contributes to the development of plaques in 
the inner wall of the arteries, a condition known as atherosclerosis.  Plaques can restrict 
the blood flow to the heart and if they burst, they can form clots.  Blood clots can cause 
the blockage of the small blood vessels in the heart that leads to heart attack.  
Furthermore, if clots block blood vessels in the brain it can cause brain stroke. [4]  The 
risk of developing heart disease or atherosclerosis increases with the increase of the level 
of cholesterol in blood.  The normal range for total blood cholesterol is between 140 and 
200 mg per decilitre (mg/dL).  The levels between 200 and 240 mg/dL indicate moderate 
risk, and levels above 240 mg/dL indicate high risk for coronary heart disease.  
Triglycerides are another form of fat in the blood stream, and high levels can increase the 
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risk for heart disease.  If triglyceride level is at the border line or more than normal then 
medical treatment is necessary. [4]  Table 1 shows the guideline developed by the 
National Cholesterol Education Program (NCEP) of the National Heart, Lung and Blood 
Institute, National Institutes of Hearth (NIH) and the National Cholesterol Education 
Program (NCEP). [4, 7]  
Table 1.  Serum Cholesterol and Triglyceride Levels (mg/dL) 
Total Cholesterol 
Less than 200 Desirable 
200-239 Borderline High 
240 and above High 
LDL Cholesterol 
Less than 100 Optimal 
100-129 Near optimal/above optimal 
130-159 Borderline High 
160-189 High 
190 and above Very High 
HDL Cholesterol 
Above 60 - 90 Desirable 
35 - 40 High 
Less than 35 Very High 
Triglycerides 
Less than 100 Normal 
100 - 149 Borderline High 
200 - 399 or above 400 Very High Risk 
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Cholesterol, like fat, is insoluble in water; however, it is transported in the blood 
by water-soluble proteins, which have been classified on the basis of their densities.  
Very low-density lipoproteins (VLDL) serve mainly to transport triglycerides.  Low 
densities lipoproteins (LDL), known as bad cholesterol, carry cholesterol to different 
parts of the body.  In the LDL form, cholesterol is transported and supplied to different 
body tissues.  LDL carries about 60-70 percent of the cholesterol around the body.  
Studies show that excess blood cholesterol leads to a much higher risk of heart attack and 
stroke.  The LDL- cholesterol level should be less than 160 mg/dL.  Although, there are 
other factors that can cause an increase in the blood cholesterol level such as age, gender, 
smoking, family history of heart disease, and diabetes mellitus, high dietary cholesterol is 
a major contributing factor that should not be ignored. [3-5] 
High density lipoprotein (HDL) is involved in the transportation of cholesterol in 
the opposite direction, that is, from the tissues and organs back to the liver for recycling.  
They are either reused, converted to bile acids, or be disposed.  HDL is called good 
cholesterol and high HDL levels are a good indicator for a healthy heart because less 
cholesterol is present in the blood.  HDL also helps to reduce the risk of heart attack and 
stroke because they consist of more protein than that of triglycerides or cholesterol and 
they work hard to remove LDL from the walls of arteries.  The HDL level should be 
more than 60 mg/dL, the higher the HDL the lower the risk for heart disease.  However, 
if the HDL level is less than 40 mg/dL then we are in a higher risk for coronary heart 
disease.  Numerous studies show that women have a higher HDL level than men and this 
is caused by estrogen, which tends to elevate HDL level in both men and women. [8] 
Regular exercise is associated with increasing the HDL level and alcohol consummation 
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between one or three ounce a day may also help increase the HDL concentration. [7, 10] 
Biosynthetic Pathway of Cholesterol 
Cholesterol, containing 27 carbons, suggests a complex biosynthetic pathway 
from a single pre-cursor of acetic acid. [2]  Cholesterol, like a long chain fatty acid is 
made from the two-carbon acetate group of acetyl-CoA.  This process occurs in four 
stages.  In the first stage, the three acetate units condense to form a six carbon 
intermediate, mevolonate, where the two molecules of acetyl-CoA condense to form 
acetoacetyl-CoA.  Stage two involves the conversion of mevalonate into activated 
isoprene units, when three phosphate groups are transported from ATP molecules to 
mevolonate.  In the third stage, the isopentenly pyrophosphate and dimethylallyl 
pyrophosphate undergo a head-to-tail condensation where one pyrophosphate group is 
displaced and the 10-carbons chain becomes geranyl pyrophosphate.  In the final stage, 
the cyclization of squalene forms the four rings of the steroid nucleus.  Furthermore, 
series of changes, oxidations, removal or migration of methyl groups, lead to the 
production of cholesterol.  Figure 2 illustrates the biosynthetic pathways of cholesterol.  
 The acetyl-CoA used for cholesterol biosynthesis is derived from an oxidation 
reaction (fatty acids or pyruvate) in the mitochondria and is transported to the cytoplasm 
by the same process as that described for fatty acid synthesis.  Acetyl-CoA can also be 
derived from cytoplasmic oxidation of ethanol by acetyl-CoA synthetase.  All the 
reduction reactions of cholesterol biosynthesis use nicotinamide adenine dinucleotide 
phosphate (NADPH) as a cofactor. [2, 5] 
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 Figure 2.  Overview of Cholesterol Biosynthesis  
 
 The isoprenoid intermediates of cholesterol biosynthesis can be diverted to other 
synthetic reactions, such as those for an isoprenoid compound similar to cholesterol that 
is used in the synthesis of N-linked glycoproteins, coenzyme Q (of the oxidative 
phosphorylation) pathway or the side chain of heme.  Additionally, these intermediates 
are used in the lipid modification of some proteins.  Acetyl-CoA units are converted to 
mevalonate by a series of reactions that begins with the formation of 3-hydroxy-3-
methylglutaryl-CoA (HMG-CoA). [2, 3] 
 HMG-CoA is converted to mevalonate by 3-hydroxy-3-methylglutaryl-CoA 
reductase (HMGR); this enzyme is bound in the endoplasmic reticulum (ER).  HMGR 
 15
absolutely requires NADPH as a cofactor and two moles of NADPH are consumed 
during the conversion of HMG-CoA to mevalonate. [2]    
The synthesis and use of cholesterol must be tightly regulated in order to prevent 
over-accumulation and abnormal deposition within the body.  The abnormal deposition of 
cholesterol and cholesterol-rich lipoproteins in the coronary arteries eventually leads to 
atherosclerosis and is considered as the leading contributory factor in diseases of the 
coronary arteries.  Cholesterol synthesis is a very complex and energy expensive process; 
therefore, it is advantageous to an organism to be able to regulate the synthesis of 
cholesterol to complement dietary intake.  Unregulated cholesterol production can lead to 
serious health problems. [7, 10]      
Cardiovascular Disease 
 Cholesterol has a profound effect on our health and it is very important to 
understand this fact about cholesterol as well as finding a way to manage blood 
cholesterol level.  Cardiovascular disease (CVD) is one of the leading causes of 
morbidity both man and women of any ethnicity.  Each year, almost half a million deaths 
in the United State are caused by cardiovascular disease and 160,000 of those deaths are 
in individuals who are 35 to 64 years of age.  According to studies conducted by the 
Center for Disease Control (CDC), lifestyle behaviors and environmental pollution can be 
factors for causing a heart disease as well. [4, 7]   
Cholesterol is the most publicized lipid because of the strong correlation between 
high level of cholesterol in blood and incidences of human cardiovascular disease.  Most 
often, the final blow from cardiovascular disease is either a heart attack or a stroke.  
These disasters are often associated with thrombus, a blood clot that blocks a key artery.  
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If the thrombus blocks one of the coronary arteries that supply blood to the cardiac 
muscle, a heart attack occurs.  A thrombus that causes a heart attack may form in a 
coronary artery itself or it may develop elsewhere in the circulatory system and reaches a 
coronary artery via the bloodstream.  Such a moving clot is called an embolus.  Similarly, 
many strokes are associated with a thrombus or an embolus that clogs an artery in the 
brain, and, therefore, the brain tissue that is supplied by that artery dies. [7, 8, 10]  
The suddenness of a heart attack or stroke belies the fact that the arteries of most 
victims had become gradually impaired by arteriosclerosis.  Arteriosclerosis is associated 
with high level of cholesterol in the blood and particularly a higher LDL level and can 
greatly increases the risk of a blood clot plugging an artery.  The narrowing of blood 
vessels does not occur suddenly but builds up over several years when cholesterol and fat 
transform the smooth muscle cells lining the blood vessels into thickened plaques that 
can become hardened by calcium deposits, resulting in a form of arteriosclerosis or 
hardening of the arteries.  This causes the arteries to become constricted, diminishing 
their elasticity and reducing the volume of blood able to travel through them at any time.  
Healthy arteries have smooth linings, but the rougher lining of an artery affected by 
atherosclerosis encourages the adhesion of platelets that triggers the clotting process.  
Arteriosclerosis causes more deaths from heart disease than any other single condition. 
[6-10] 
Hypertension (high blood pressure) promotes atherosclerosis and increases the 
risk of heart attack and strokes as well.  Hypertension is sometimes referred to as the 
silent killer because a person with this disease may experience no symptoms until the 
tragedy occurs.  Fortunately, hypertension is simple to diagnose and can usually be 
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controlled by drugs, diet, and exercise.  To some extent, the tendency for hypertension 
and atherosclerosis is inherited, making certain people more predisposed than other to 
cardiovascular disease.  Smoking, lack of exercise, and a diet rich in animal fats and 
cholesterol are among the factors that have been correlated with increased risks of 
cardiovascular disease. [7] 
Besides diet, the increased serum cholesterol level can also caused by underlying 
diseases such as diabetes mellitus, kidney disease, liver disease, or hypothyroidism.  It 
also can be caused by an inherited disorder in which cholesterol is not metabolized 
properly by the body.  Obesity, which generally results from eating a diet high in fat, also 
can lead to elevated blood cholesterol levels.  This is because obesity itself leads the body 
to produce excessive amounts of cholesterol.   Hypercholesterolemia is a condition of 
high level of cholesterol in the blood that can lead to atherosclerosis that increases the 
risk for heart attack, stroke, circulation problems, and death. [8] 
  Familial hypercholesterolemia is also a syndrome that is due to a high level of 
low-density lipoprotein (LDL).  Approximately 85% of men with this disorder have 
experienced a heart attack by the time they reach 60 years old.  Among the affected 
males, a first heart attack typically occurs in their 40s to 50s.  The incidence of heart 
attacks among women with this disorder is also increased.  However, it is delayed by 10 
years as compared to men.  In contrast, the HDL level is nearly the same in both men and 
women for the first 15-20 years of life and then it declined by about 20-25% in men but 
by a lower percentage in women. [8, 10] 
Symptoms of high cholesterol usually are rare.  High cholesterol levels are 
generally identified from a blood test.  The primary symptom associated with coronary 
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heart disease is called angina (chest pain).  When a person experiences this, he or she 
describes a feeling of pressure, squeezing, or a general feeling of someone sitting on their 
chest.  These symptoms can spread to the jaw, neck, or arm regions of the body.   Initially 
the symptom will start with pressure in the chest region; however, some individuals 
experience that feeling of pressure in other areas and not the chest.  In addition to the 
reported pressure, other symptoms include nausea, shortness of breath, sweating, 
lightheadedness or dizziness, and heart palpitations. [6, 7]  With blood flow impeded, the 
heart becomes starved for oxygen, causing angina.  Angina can be directly correlated to 
coronary heart disease and should be taken seriously.  However, there are other stressors 
such as over-exertion, extreme emotion, or even after eating a huge meal.  In these 
circumstances, a short period of rest, five minutes or so, will reduce or eliminate the 
symptoms.  Again, if one has any of these symptoms, it is better to be checked out by a 
physician than to assume everything is fine.   
Stroke is also one of the leading causes of deaths in the U.S.  There are four 
primary symptoms pertaining to a stroke, although most of the time this is a sudden event 
with little or no warning.  The sudden onset of numbness or weakness of face, arm, or 
leg, especially on one side of the body, confusion, difficulty speaking or understanding, 
sudden trouble with vision in one or both eyes and dizziness, loss of balance, and lack of 
coordination are of the symptoms.  Other common signs include nausea and vomiting, 
fever and fainting, convulsions. [7-10] 
Peripheral vascular disease is caused by high cholesterol in which the arteries that 
carry blood to our extremities become narrow or clogged.  The outcome is that the blood 
flow is slowed down or stopped completely.  The symptom includes numbness or tingling 
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in the lower extremities, a cold sensation in the lower extremities and open sores or ulcers 
on the lower extremities that do not heal normally.  
Lipid-Lowering Treatments 
Lifestyle and eating excessively “rich” diets and obesity have contributed to a 
dramatic increase in the occurrence of cardiovascular disease.  Many studies have shown 
that a high serum concentration of low density lipoproteins cholesterol (LDL-C) is a 
major risk factor for coronary heart disease (CHD).  Lowering of LDL-C level will 
reduces the risk of major coronary event.   Drug therapy also can be considered for 
lowering the blood cholesterol level.  Additionally, dietary therapy, regular physical 
activity, and weight loss can be prescribed treatment for elevated blood cholesterol levels.  
However, the treatment of high cholesterol is aimed at lowering the LDL-C, lowering 
triglyceride levels, and increasing the HDL or good cholesterol.  The most effective lipid 
lowering agents are the 3-hydrox-3-methylglutaryl-coenzyme, a reductase inhibitor, more 
commonly known as statins. [6, 8]  
Currently, a number of lipid lowering drugs available in the United State includes 
bile-acid sequestrants, cholesterol-absorption inhibitors, fibric-acid derivatives, statins, 
and niacin/nicotinic acid as shown Table 2.  Statin is the primary treatment for patients 
who are at high risk of CHD.  There are six types of statins such as lovastain (Mevacor), 
Atorvastatin (Lipotor), Cerivastatin (Baycol), fluvastatin (Lescol), Pravastatin 
(Pravachol), and Simvastatin (Zocor).  These six types of statins differ in their 
effectiveness in reducing serum cholesterol. [8, 9] 
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Table 2.  Available Lipid-Lowering Drugs 
Statins 
Avorvastatin (Lipotor) Lovastain (Mevacor) 
Fluvastatin (Lescol) Cerivastatin (Baycol) 
Pravastatin (Pravachol) Simvastatin (Zocor) 
Nacin/nicotinic Acid 
Extended Release  
(Naspan) Immediate Release 
Fibric-acid Derivatives 
Fenofibrate Gemfibrozil 
Bile-acid Sequestrannts 
Cholestyramine Colesevelam 
 
Statins can block the conversion of HMG-CoA to mevalonate reductase that 
controls the rate of cholesterol production in the body. This results in an increase in 
hepatic LDL receptor expression to enhance the removal of apo B lipoprotein containing 
particles from the circulation and lower the total cholesterol, LDL-C, and triglycerides.  
Statins can lower the blood cholesterol level by slowing down the production of 
cholesterol and by increasing the liver's ability to remove the LDL-cholesterol already in 
the blood.  Additional benefits of statins include atherosclerotic plaque stabilization, 
positive effects on endothelial dysfunction, and reduced level of C-reactive proteins all of 
which has been associated with CHD.  Statins do show low side effects including hepatic 
or muscle toxicity and it is advisable to avoid using higher dose. [6, 9, 10] 
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Lovastatin is a natural product, while simvastatin and prevastatin are semi-
synthetic products. [6]  Atorvastatin is the most effective statin and has the ability to 
reduce the LDL-C level by about 52 % to 55 % at its highest dose of 80 mg.[6]   
Pravastatin and fluvastatin show nearly 34 % LDL-C reduction at their higher doses.  
However, lovastatin and simvastatin reduce cholesterol by about 6 % and 12 % at their 
higher dose.  
Another class of drugs for lowering LDL is the bile acid sequestrants (BAS) such 
as cholestyramine, colestipol, and, nicotinic acid (niacin). [8-9]  These have been shown 
to reduce the risk for coronary heart disease in controlled clinical trials.  Bile acid 
sequestrants interrupt the enterohepatic circulation of bile acids by binding with them in 
the bowel to form an insoluble complex that is excreted in the stool.  Bile acid depletion 
leads to an increase in hepatic LDL cholesterol receptor expression and consequently a 
fall in total and LDL cholesterol levels.  The BAS drugs have been used for more than 
three decades and are moderately effective in lowering LDL-C levels from 15 % to 25%. 
[6]  However, there are some side effects including gas bloating and constipation.   
Niacin (nicotinic acid) is a water-soluble B-Complex vitamin, inexpensive and 
widely accessible to patients since the 1950s. [6]   It is also another type of lipid lowering 
drug and can increase the concentration of HDL while decreasing the concentration of 
LDL level.  Niacin undergoes two major metabolic pathways, one involves conjugation 
with glycine to form nicotinuric acid and it is associated with the flushing of niacin.  The 
conjugate pathway is a low affinity, high-capacity pathways that are used when the non-
conjugative pathway is saturated.  However, they have significant problems for patients 
with higher LDL level because they are associated with flushing or hot flashes, abnormal 
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liver function, and other problems. [8]   Dietary supplement niacin must not be used as a 
substitute for prescription niacin.  If physician approves, over-the-counter niacin can be 
used as a substitute.  But it must not be used for cholesterol lowering without being 
monitored by a physician because it is associated with flushing and skin irritation of the 
face and neck. [6-8]  All patients taking niacin to lower blood cholesterol should have 
their doctor closely monitor them to get the best effect and to avoid complications.  Self-
medication with niacin should definitely be avoided.  
 The large reductions in total blood cholesterol level and LDL-C produced by 
these drugs resulted in large reductions in heart attacks and heart disease deaths.   The 
main goal of cholesterol-lowering treatment is to lower LDL level enough to reduce the 
risk of having a heart attack or other diseases caused by hardening of the arteries. [6-9, 
10] 
Cholesterol is essential for normal functioning of the immune system, particularly 
for the body’s response to the millions of cancer cells that every person makes in the 
body each day.  For all the health problems associated with cholesterol, this important 
substance is not something we should try to eliminate from our bodies. Cholesterol does 
far more good than harm.  The good news is that all these can be brought under control 
either by changes in lifestyle such as diet, losing weight, an exercise program, or quitting 
a tobacco habit.  Drugs also may be necessary in some people. Sometimes one change 
can help bring several risk factors under control.  For example, weight loss can reduce 
blood cholesterol levels, help control diabetes, and lower high blood pressure. 
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CHAPTER 2 
ANALYSIS OF CHOLESTEROL 
The determination of cholesterol content in either serum or foods has been the 
subject of extensive research.  The need for suitable analytical methods for the 
determination of total cholesterol in biological blood and food product is highly 
significant for both our health and nutrition.  Cholesterol determination is a valuable aid 
to diagnosis and treatment in a variety of clinical states, such as arteriosclerosis, thyroid 
metabolism, diabetes, and other disorders. [10-12]  However, clinical laboratories are 
often unable to keep pace with the growing demand for these determinations because of 
the challenging and unique requirements placed on the techniques.  The methods that are 
developed for the analysis of cholesterol present in the blood and for any of its fractions 
have proceeded through several pathways.  Many different analytical approaches have 
been described for the analysis of cholesterol and its esters.    
 In late nineteenth century, Salkowski [13] described the first color reaction, 
where his analyte was isolated from gallstones.  The combination and digitonide 
precipitation for purification of color reaction for quantification led to the first 
colorimetric procedure for serum reaction based on the gravimetric method of Windaus. 
[13]  Digitonin was one of the specific reagents commonly employed for precipitating the 
cholesterol for its determination.   
 Methodologies for determinations of total cholesterol are subdivided into two 
main groups, extraction and direct methods.  In the extraction methods the cholesterol is 
extracted from the serum into a suitable solvent, and after purification the cholesterol is 
subjected to a color reaction. [14]   In the direct reaction methods, the reagents are added 
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to the sample without fractionation of the sample because the proteins are removed 
before measurement is allowed to take place.   Additionally, there is no phase separation 
in direct reactions.  Furthermore, the analyses of cholesterol are divided in two 
categories, non-enzymatic and enzymatic reactions.  Non-enzymatic reactions involve the 
formation of color compounds.  In contrast, the enzymatic reactions involve reaction 
between free cholesterol with cholesterol oxidase to generate hydrogen peroxide.   The 
hydrogen peroxide can then be determined by various techniques.  There are some 
significant differences between the non-enzymatic and enzymatic methodologies.  The 
non-enzymatic method is more time consuming and requires the use of corrosive 
chemicals, whereas enzymatic reaction is fast and uses a direct assay and can be an 
automated procedure.  [14, 15] 
Lieberman-Burchard Reagents  
The colorimetric methods for the determination of cholesterol are based upon the 
original reaction of Liebermann and Burchard, but often they differ in the extraction 
procedure.  Liebermann-Burchard (L-B) reagent is one of the most significant and widely 
used reagents for non-enzymatic method of production of color.  The reactions were 
described initially by Lieberman in 1885 [16] in which the reaction of cholesterol in 
acetic anhydride with sulfuric acid produced color that went from red through violet to 
blue-green.  Burchard [16] applied the reaction to determine cholesterol in CHCl3 instead.   
It was believed that the acetic anhydride served only as a diluents for the sulfuric acid 
because acetic anhydride can be replaced by acetic acid, ethyl acetate, or butanol.   
The Lieberman-Burchard color reaction is complex and can be affected by many 
variables including concentrated sulfuric acid, glacial acetic acid, length of reaction, 
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light, and temperature.  Since the L-B reagent is unstable, it is prepared fresh daily before 
performing the reaction and it is to be stored at low temperature.  The reaction produces 
stable color between 430 to 630 nm.  However, the green color at the maximum peak of 
620 nm was more stable than the blue L-B color. [17]   
In the early nineteenth century, Kim and Goldberg [18] developed a technique for 
serum cholesterol assay using a stable reagent. The reagents were prepared just as 
Liebermann and Burchard prepared them, using glacial acetic acid, acetic anhydride, and 
sulfuric acid.  They pipetted 6.0 mL of the reagent and mixed it with 0.1 mL of the 
unknown sample or with 0.1 mL of cholesterol standard (200 mg/d).  The mixtures were 
incubated at 37 0C for about 18 min and absorbance measured at 625 nm.  However, 
Burke and his coworker [19] indicated that the L-B and Zak color reactions had similar 
oxidative mechanisms with the active oxidants of SO3 and Fe3+.  Further evidence 
showed their similarity where the L-B reaction was performed in acetic acid, sulfuric 
acid, and acetic anhydride medium, except for Zak [15] reaction which was performed 
using iron (III) for color production instead of acetic anhydride.  The color study also 
indicated that the color species observed in the two systems are enylic carbonium ions 
formed during the protonation of the parent polyenes.  The red product from Zak reaction 
was a cholestateraenylic cation, but the blue color from L-B reaction was the pentaenylic 
cation.  
The L-B reagent has been modified in many different ways for the determination 
of cholesterol in serum; however, the color production per molecule differs for pure 
cholesterol and for total cholesterol in serum.  The reason for this difference is because 
the cholesterol in serum is present as esters with long-chain fatty acid instead of free 
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cholesterol.  It also can be because the L-B reagent interacts differently with the matrix of 
serum.  However, L-B reagent seems to give a better result when it is used in a direct 
method compared to the other methods mentioned above. 
Non-Enzymatic Method of Cholesterol Analysis 
Non-enzymatic procedures involve the reaction of cholesterol with certain 
reagents that result in the production of color products obeying Beer’s Law over a wide 
analytical range.  
Non-enzymatic methods used for the determination of total serum cholesterol 
were very tedious and errors may result from incomplete cholesterol extraction.  These 
sources of error were eliminated in a new rapid and accurate method of Pearson, Stern, 
and McGavack. [20]  In 1952, they introduced a method in which cholesterol in serum is 
reacted directly with p-toluenesulfonic acid.   In this method, glacial acetic acid, p-
toluenesulfonic acid, and acetic anhydride were added directly to serum followed by 
addition of concentrated sulfuric acid.   The determination was carried out in test tubes in 
a short time.  They found that the color was stable for 10 to 15 minutes.  The color 
stability was measured in the range of 550 to 650 nm and the absorption maximum was at 
650 nm.  However, the color density seems to differ with time.  
Cholesterol, as well as other steroids, give intense colors when treated with Lewis 
acids, and the actual color produced depends on the specific acid used, its concentration, 
as well as other variables.  In 1953, Zlatkis [13, 14] presented the first automated, 
sensitive, and stable color reaction for the simple determination of serum cholesterol by 
direct treatment of the serum with a reagent consisting of ferric chloride dissolved in 
glacial acetic acid.  Full development of the purple color appeared in one minute. The 
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rates of color formation between cholesterol and cholesterol ester were identical.  
Additionally, precision and reproducibility were demonstrated with the absorption 
characteristic of color product through the spectral ranges of 400 to 700 nm. [17]  The 
result followed Beer’s Law and the color remained stable for several hours.  Zak’s direct 
reaction method was highly satisfactory because color formation was stable and it had 
good sensitivity.   
In 1964, Jamieson [21] modified Pearson’s technique for an automated direct 
cholesterol determination without preliminary solvent extraction. The reagents used in 
Pearson’s method were also used in Jamieson’s procedures but with slightly different 
concentration, volumes, and temperatures.  The time for the color production was 
increased to 50 minutes rather than 30 minutes.  The procedure did not require high 
concentration of toluene-p-sulphonic acid and it was found that keeping the concentration 
of sulfuric acid close to 15 % was very important.  Lower concentration of sulfuric acid 
resulted in incomplete dissolution of the protein and led to instrumental fluctuations.  
More importantly, the automated method was fast, requiring only a very small amount of 
serum, and was very economical in terms of reagents.  Furthermore, there were fewer 
sources of error compared with the more elaborate extraction method.  Jamieson’s 
automatic method, using a variable temperature heating bath, required about 0.2 mL of 
serum, standard, and reagents, showed satisfactory results for measuring serum and 
standard cholesterol.  Compared with manual methods, there was no significant 
difference in the result.   Jamieson’s method was fast, stable, and more accurate than 
Pearson’s method.  
Wybenga and co-workers [22] described a simple, direct, and specific manual 
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method for determination of total cholesterol in serum.  Their method did not require the 
extraction of cholesterol from the serum and was relatively free of interference from 
hemoglobin.  Like the method of Zlatkis [14] the reactions were performed using a 
mixture of sulfuric acid, acetic acid, and ferric chloride. The only difference was the 
addition of a 50 µL of sample of cholesterol standard in Wybenga’s method.  The 
maximum color was achieved within 30 minutes at room temperature similar to Pearson’s 
method.  The results obtained by Wybenga et al. did not differ statistically from those 
obtained by the method of Abell and coworkers. [18]    
In 1982, Abell’s reaction [16, 18] was performed for direct addition of 
Liebermann-Burchard reagent to cholesterol sample.  Their results were calibrated with 
human serum pools assayed.  Accuracy and precision were monitored for six years by 
analysis of internal-control pools and blind external-control pools.  For the various 
internal controls pool the imprecision of the long-term averages ranged from 0.5 to       
0.9 %.  It was concluded that the use of serum calibrator eliminated the bias inherent in 
direct L-B methods because the color yield per molecules differs for cholesterol in serum 
and pure cholesterol in calibration solutions. 
The determination of serum cholesterol has changed from a comparatively time-
consuming procedure to simpler and more rapid technique.  Bowmen and Wolf [23] had 
examined the absorbance spectrum of Zlatkis’s cholesterol reaction.  The reaction 
showed not only the expected peak at 560 nm but also an additional higher peak at 490 
nm.  Under the optimum condition of time and color reagent, the 480-nm peak 
approximately double the sensitivity for cholesterol determination as compared to the 
560-nm peak. The observed interference of iodide in Zlatkis reaction resulted from an 
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enhancement effect of the color by the cholesterol itself.  However, adding an extra 100 
µg NaBr per milliliter of glacial acetic acid produced 50 % greater color and eliminated 
interference at 560 nm.  
Enzymatic Method of Cholesterol Analysis 
 
Enzymatic methods of analysis are becoming very important in food.  Clinical 
chemistry also has benefited from the advantages in the use of enzymes for analytical 
purposes.  Enzymes are biological catalysts that enable many complex chemical reactions 
to proceed at a reasonable rate.  Several enzymatic methods for free cholesterol 
determination and total cholesterol had been published. [26-29]  Enzymatic determination 
of total cholesterol is based on the hydrolysis of esterified cholesterol catalyzed by 
cholesterol esterase (CE) to free cholesterol.  The free cholesterol is then oxidized in the 
presence of cholesterol oxidase (COD) to yield the corresponding ketone (cholest-4-en-3-
one) and hydrogen peroxide, as shown in equations 1 and 2. 
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Cholesterol ester (CE) and free cholesterol can be measured after enzymatic reaction 
using either colorimetric or fluorometric methods.  Furthermore, CE content in human 
plasma, rat liver, and culture cell can be measured using the above methodology and its 
usefulness evaluated.   
Huang and his associates [24] had described a fluorometric enzymatic method for 
determining total serum cholesterol based on the hydrolysis of cholesterol esters to free 
cholesterol.  They described the procedure in which free cholesterol was oxidized by 
oxygen gas in the presence of cholesterol oxidase to cholest-4-en-3-one and hydrogen 
peroxide.   A calibration curve was constructed form the collected data on a series of 
standard cholesterol solutions versus the fluorescence change (Δf/5 min).   The curve was 
linear up to 4.0 g of total serum cholesterol per liter of serum with correlation coefficients 
of about 0.98.  This method was specific, precise, accurate, rapid, and simple.   
Moreover, the results correlated well with both Liebermann-Burchard procedure and the 
colorimetric enzymatic method.     
Amundson et al, [25] described a simple and sensitive fluorometic assay for the 
enzymatic determination of cholesterol in serum and food samples.  The complete 
reaction mixture of the Amplex red-based cholesterol assay contain Amplex Red, 
cholesterol oxidase, cholesterol esterase, HRP (horseradish peroxidase), and cholesterol. 
The assay was performed in one step using a 96-well microplate.  The assay allowed the 
detection of 5 pmol (2 ng) cholesterol per well, which is 100-fold more sensitive than the 
fluorometic and colorimetric methods.  In addition to its high sensitivity, the Amplex 
Red-based cholesterol assay showed excellent linearity for cholesterol concentration from 
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10 nM to 10 µM.  This method was superior as it used longer wavelength spectra that are 
less susceptible to interference from biological compounds. 
 Allain and his associates [26] described the enzymatic hydrolysis of cholesterol 
esters and the colorimetric measurement of peroxide by a peroxidase coupled reaction 
with 4-aminoantipyrine and phenol.  This procedure was adapted to continuous-flow 
automated procedure for serum cholesterol using the AutoAnalyzer II.  The calibration 
curve showed linearity at 600 mg/dL.  This method is reproducible and the result 
correlated with automated Liebermann-Burchard procedure and the method of Abell et al.  
Enzymatic Flow Injection Analysis (FIA) 
 Flow injection analysis has been used for the determination of total cholesterol 
level in the presence of various enzymes such as cholesterol oxidase, cholesterol esterase, 
and peroxidase.   
Fernandez-Romero and co-workers [27] had proposed four different flow 
injection methods for enzymatic determination of total cholesterol in serum.   Using the 
merging-zones or merging zone/stopped flow procedure with a photometric or 
fluorimetic detection, they developed four different precise methods for cholesterol 
analysis.  The first two steps are the enzymatic reactions involving cholesterol esterase 
and cholesterol oxidase.  However, the third step depended on characteristic of the 
detection systems.  The first step was the catalyzed hydrolysis of cholesterol ester by 
cholesterol esterase (CE) to generate free cholesterol and fatty acid.  The second step was 
the oxidation of free cholesterol by atmospheric oxygen in the presence of cholesterol 
oxidase (COD) to produced cholest-4-en-3-one and hydrogen peroxide.  The horseradish 
peroxidase (HPOD) catalyzed the reaction of hydrogen peroxide with 4-aminoantipyrene 
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and phenol to generate highly colored quinoneimine dye with maximum absorbance at 
520 nm.  Both free and esterified cholesterol, are determined in the absence and presence, 
respectively, of cholesterol oxidase.  Their reaction time was 10 min at 37 oC.  The 
calibration curves were linear for ranges of 0.020 – 0.20 and 0.005 – 0.050 g/L and the 
method showed excellent results.     
 Richmond [28] described an assay for total and free cholesterol determination in 
serum with the use of the AutoAnalyzer II (Technicon).  An alkaline ethanolic 
hydrolyzing reagent at pH 7.5 was used to release free cholesterol from its lipoprotein 
complexes and hydrolyzed the ester.  The hydrolysis was kept at pH 7.5 to prevent 
formation of a precipitate with the addition of Hg2+.  Furthermore, the free cholesterol 
was maintained in miceller solution for enzymatic oxidation with surfactant Triton X-100 
and hydrogen peroxide was measured by reaction with Ti4+ and xylenol orange.  
 The use of immobilized enzymes for analysis has been considered to be one of the 
most important advancements in enzyme technology.  It improves enzyme stability, 
activity, re-usability, and prevents its deactivation due to environmental perturbations.   
In 1985, Masson and Townshend [29] proposed a method based on immobilization of an 
enzyme for the determination of cholesterol using flow injection analysis (FIA).  In this 
method 50 U of cholesterol oxidase were immobilized on 200 mg of controlled porosity 
glass (CPG) by cross linking with glutaraldehyde.   The cholesterol oxidase immobilized 
on CPG showed very high stability.  The calibration curves gave a linear response for 0 – 
80 mg dL-1 cholesterol with relative standard deviation of 1.0- 3.0 %.  The sample 
throughput was 80 h-1.   
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 Later, optimization of the co-immobilized cholesterol esterase and cholesterol 
oxidase on to cellulose acetate membrane was introduced by Bariyah and co-worker. [30] 
Cholesterol esterase and cholesterol oxidase which were co-immobilized by the 
adsorption method on to cellulose acetate membrane coated on glass beads.   A maximum 
adsorption of 75% for cholesterol oxidase and 63% for cholesterol esterase were obtained 
under the condition consisting of an agitation rate of 70 oscillations per min for 18 h 
using cholesterol esterase and 0.08 U/ cm2 of cholesterol oxidase at 37 oC.  A satisfactory 
stability of 8 repeated uses of the co-immobilized preparation was obtained with a t1/2 of 
15 consecutives uses.  When compared to the commercially available Sera-Pak and 
CHOD-PAP, the co-immobilized enzyme preparation showed a linearity with correlation 
coefficient of 0.95 and 0.99.   
 Moody and co-workers [31] developed an amperometric enzyme electrode in a 
flow analysis system for determination of cholesterol.  The electrode consisted of 
cholesterol oxidase immobilized on nylon mesh and held over platinum.  The electrode 
was run under +600 mV vs a silver–silver chloride reference electrode, with a carrier 
stream of 2.3 cm3 min-1 at pH 7.0 phosphate buffer containing Triton X-100 (1%).   The 
electrode exhibited linearity between 10 μL and 1.03 mM of cholesterol and it was also 
concluded that the enzyme electrode lifetime were about 6 weeks and it was governed by 
the deleterious effect of cholesterol on the surfactant of electrode.  The respective linear 
ranges were 5.17 x 10-5 – 5.17 x 10-4 and 1.30 x 10-5 – 1.30 x 10-4 mol dm-3 of cholesterol.        
 Potentiometric detection was an interesting method because of its inherently wide 
linear range.  However few studies have been done in its use for analysis of cholesterol.  
Situmorang and co-workers [32]   reported a study using flow injection potentiometry 
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(FIP) for this purpose.  They developed a method that used a tungsten wire electrode as a 
sensor vs. Ag/AgCl in conjunction with a redox mediator ferrocyanide.  Ferrocyanide is 
converted to ferricyanide by hydrogen peroxide catalyzed by peroxidase, and the tungsten 
electrode responds to the ratio of ferricyanide to ferrocyanide.  Their assays were done 
with a combination of three enzymes, cholesterol oxidase, cholesterol esterase, and 
peroxidase (POD).   Flow injection potentiometry gave well defined peaks and had very 
fast response (30 s).  Calibration curves were obtained from 0.05 to 3.0 mM cholesterol 
with a slope of 60.2 mV/decade and the detection limit was 0.01 mM cholesterol (S/N = 
3.0).  
All of these works illustrated enzymatic or non-enzymatic reactions that resulted 
in the formation of hydrogen peroxide detected either in color form or as end-point 
signal.  Generally, the determinations of serum cholesterol and cholesterol ester have 
included both enzymatic and non-enzymatic reaction with four separation steps namely: 
extraction, saponification, isolation, and end-point.  Cholesterol determinations have 
become simpler and it is generally feasible for most clinical laboratories.   
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CHAPTER 3 
LUMINESCENCE AND TECHNIQUES 
Principle of Luminescence  
 
In 1568, Cellini described the first recognized nature of luminescent diamond and 
it was about the same  times that fluorescence was discovered.  Luminescence phenomena 
have been known since ancient times and related mainly to living organisms that emit light 
including fireflies, luminous bacteria, fungi, fishes, and insects.  In 1888 Wiedemann [33] 
was the first person that defined the term luminescence to distinguish between the light 
emission from thermally excited substance and light emission from molecules excited by 
other mechanism.  He then classified luminescence phenomena into six different 
categories according to their excitation methods.  The list of the present recognized types 
of luminescence includes photoluminescence, thermo-luminescence, 
electroluminescence, crystalloluminescence, triboluminescence, and chemiluminescence.  
Photoluminescence is caused by absorption of light can be subdivided into fluorescence 
and phosphorescence.  Electroluminescence is produced in gases by an electric discharge, 
thermoluminescence is produced by slight heating, triboluminescence is a result of 
friction, crystalloluminescence a result of crystallization, and chemiluminescence is 
caused by chemical reaction. [34-36] 
 Luminescence applied to the reemission of previously absorbed radiation.  When 
a photon of electromagnetic radiation is absorbed by a molecule, the molecule is raised to 
the excited state and when it returns to the ground state, the molecule emits radiation. 
[33]  Some of the most important features of luminescent method is their inherent 
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sensitivity, low detection limit compared to absorption methods.  Additionally, it has 
large linear dynamic range and selectivity.  
Fluorescence, phosphorescence, and chemiluminescence provide some of the 
most sensitive and selective methods of analysis of many compounds.  Fluorescence and 
phosphorescence are alike in their excitation method; however, chemiluinescence was 
based on an excited species that is produced from a chemical reaction.  Generally, 
fluorescence is a phenomenon in which absorption of light of a given wavelength by a 
fluorescent molecule is followed by the emission of light at longer wavelengths. [37, 38]  
Fluorescence can occur in simple, complex gaseous, liquid, and solid chemical phase.  In 
1935, Jablonski [39] proposed the scheme of electronic energy level that becomes the 
basis of interpretation of all luminescence phenomena.  The Jablonski diagram shown in 
Figure 3 shows the activation and deactivation processes of a molecule.  
A Jablonski diagram is a partial energy diagram for a typical photo-luminescent 
molecule.  The lowest heavy horizontal line represents the ground-state energy of the 
molecules, indicating singlet state and is labeled as S0.   At room temperature this state 
represents the energy of essentially all of the molecules in a solution.  The three lines 
above S0 represent the energy levels of the ground vibrational states.  
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 Figure 3. Jablonski Energy Diagram 
 
  The upper heavy horizontals lines represent the first electronic singlet state (S1) 
and second electronic singlet state (S2).  A singlet state is a molecular electronic state in 
which all electron spins are paired, and no splitting of electronic energy level will occur 
when the molecules are expose to a magnetic field.   The energy level located on the right 
side, T1 represents triplet state.  The energy of the first excited triplet state is lower than 
the energy of the excited singlet state.   In the triple state the two electrons become 
unpaired and parallel. [37, 39] 
 The difference between the singlet and triplet state are the electronic spins, which 
are equal to + ½ and – ½.   The expressions of multiplicity are related to the spin of the 
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orbital and are used to express the orbital angular momentum of a given state. [38]  The 
term multiplicity is used to express the orbital angular momentum of a given state that is 
related to the spin by the equation 3. 
M  =   2S + 1                                      (3) 
When all the electrons are paired, S = 0, (+ ½ – ½ = 0) and the multiplicity will be a 
singlet electronic state.  However, when the spin of singlet state is reversed, the 
molecules find itself with unpaired electrons and resulted a multiplicity of 3 or called a 
triplet state.  
At room temperature, the ground singlet state S0 represents the energy of all the 
molecules in the solution.  The excitation of the molecules takes place by absorption of 
quanta of radiation of appropriate wavelength.  If the molecules absorbed energy equal to 
the energy difference between the ground state and one of the excited single states, then 
the molecules are raised to that excited single state.  
Deactivation Process 
There are several mechanisms as illustrated by the Jablonski diagram that an 
excited molecule, can return to its ground state.   Fluorescence and phosphorescence 
involve the release of a photon returning to S0 from the lowest singlet excited state S1 or 
from the triplet excited state T1, respectively. The different processes responsible for the 
dissipation of the excess energy of an excited species can be classified as in Figure 4. 
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  Figure 4. Pathways for the Dissipation of Electronic Energy 
The non-radiative relaxation processes are so efficient that the average lifetime of 
a vibrationally excited molecule is about 10-12 sec.  In solution, the excess vibrational 
energy is immediately lost as a consequence of collisions between the molecules of the 
excited species and those in the solvent, resulting in energy transfer and an increase in the 
temperature of the solvent.   This means that most excited state molecules never emit 
energy from higher electronic states.  This process is known as vibrational relaxation. 
[39] 
Internal conversion (IC) occurs when a molecule is de-excited from a lower 
vibrational level of the upper excited state (S2) to the higher vibronic levels of the lower 
excited state (S1). [39]   Internal conversion appears to be very efficient when two 
electronic energy levels are sufficiently close for there to be an overlap in their 
vibrational energies.  IC through the overlapping vibrational level is usually more than 
the loss of energy by fluorescence from a higher excited state.  IC may also results in 
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phenomenon of pre-dissociation, where the electron moves from the higher electronic 
state to the upper vibrational level of the lower electronic singlet state. [38-39]   
 In molecules where the singlet S1 and the triplet T1 energy level are closely 
spaced the molecules can drop into the lowest energy T1 state through a process known as 
intersystem crossing (ISC). [39]  Sometimes under the right conditions the molecules 
may flip its spin and get to the triplet state. This process is normally a forbidden 
transition.  However, due to spin orbital coupling ISC may take place between 10-3 to 10-4 
s, a relatively slow process.  When energy is applied some molecules will reverse the 
intersystem crossing process to bring molecules back to the singlet state.  ISC is the most 
common for molecules containing heavy atoms.  ISC can decrease the occurrence of 
fluorescence and increase the probability of populating the triple state.  Transitions from 
the triplet excited state to the singlet ground state are forbidden.  However, when the 
molecules returned to the ground state S0 by emission of radiation from the T1 to S0 
phosphorescence occurs.    Phosphorescence is observed in transition times of 10-4 to 10 s.  
An after glow is one of the characteristic features of phosphorescence because emission 
tends to continue after the exciting source is removed.  Because of the relatively long 
lifetime of the triplet state, molecules in this state are much more susceptible to 
radiationless deactivation processes. [37-39]   Fluorescence is statistically much more 
likely than phosphorescence.      
 Deactivation of an excited molecule involved with interaction and energy transfer 
between with other molecules or solvent molecules are known as external conversion or 
collisional quenching.  Quenching results from a specific interaction between a 
fluorophor and another substance present in the system. [37-38]   
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Fluorescence quenching is a process which decreases the intensity of the 
fluorescence emission.  The general mechanisms for quenching are given below.  In these 
equations, M represent the fluorophor, Q is the quencher, and M* is the excited  
fluorophor.      
M + һυ               M*   (light absorption)     (4) 
 M*                     M + һυ (fluorescence emission)     (5) 
M* + Q              Q*  +  M (quenching )     (6) 
      Q*                  Q  +  energy       (7) 
 
Quenching can occur via collision (dynamic quenching), charge transfer reaction, 
and energy transfer.  Dissolved oxygen [37, 38] is the most common luminescence 
quencher and removal of oxygen from the sample before luminescence analysis is 
advisable.   
The Principle of Chemiluminescence 
The phenomenon of chemiluminescence (CL) was first discovered in the mid-
nineteen century by Radziszewski.  In 1877, Radziszewski [42] reported the green light 
emitted by reaction of organic compounds.  The emitted green light was observed from 
lophine (2, 4, 5 –triphenylimidazole) reacting with oxygen in the presence of a strong 
base.  
  Visible radiation that is observed when chemical reaction yields an electronically 
excited intermediate or products that either luminesce or donate its energy to another 
molecule that can luminesce is called chemiluminescence.  If radiation is emitted by 
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energy transfer, it is known as chemi-excitation.  When the chemical reaction is 
enzymatic or occurs in living organisms, the phenomenon is named as bioluminescence 
(BL).  [41] 
Many more CL reactions were discovered during the early 20th century.  In 1905, 
Trauzt [42] described and published a review of known CL and BL reactions and he 
attributed the reaction to active oxygen.  In his study, he described more extensively the 
CL and the luminescent properties of the reaction from the organic compounds with 
oxidants.   In 1927, Mallet [42] discussed energy transport to fluorophores and in 1928, 
Albrecht [43] reported the intense luminescence associated with alkaline oxidation of the 
most widely used CL reagent known as luminol (5-amino-2, 3-dihydro-1, 4-
phthalazinedione).  
Generally, a CL reaction can be generated by two basic mechanisms.  In the direct 
reaction involving two reagents, a substrate and an oxidant react in the presence of a co-
factor to form a product which is chemiluminescent.  The product is formed in the 
electronically excited state that can subsequently relax to the ground state with the 
emission of a photon as shown by the equations below: 
 
  A  +  B                        C*  +  D       (8) 
C*                      C   +  һυ      (9) 
 
A and B represent the reactants and C* is the excited stats of the product.  The indirect or 
sensitized CL reaction is based on energy transfer of the excited species to a fluorophore.  
The following reactions summarize the process. 
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 A  +  B                     P*  +  D                              (10) 
    P*  +  F                   P  +  F*                                     (11) 
     F*                    F  +  һυ               (12) 
 
 In step one, a key excited intermediate P* is formed by a reaction.  In the second 
step the chemical energy of the intermediate is transferred to excite the fluorphore F.  
Finally, the CL occurs when the excited fluorophore F* returns to the ground state with 
the emission of light.  
 Three conditions are required for CL reaction.  First the chemical reaction must be 
highly exothermic to release sufficient energy to populate the excited state molecules.  
Secondly, the reaction pathway must favor the formation of the excited state product.  
Finally, the excited state product must be capable of emitting a photon itself or 
transferring its energy to another molecule that can emit. [44, 45]   
In all luminescent processes, intensity of CL (ICL) depends on the efficiency of the 
formation of excited state molecules to luminesce, which is represented by quantum 
efficiency (ФCL).  Thus ICL is given by the following.  
 
 The CL quantum yield is actually express as a product of two efficiencies: [37-38] 
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where Φex equals the ratio of the number of electronically excited molecules formed 
divided by the number of the molecules reacted.  The ΦL is the luminescence efficiency 
of the luminescent species and it equals the fraction of the number of photons emitted 
divided by the number of electronically excited molecules formed.  Therefore, CL signal 
decreases over a period of time after the reagents are consumed.  
There are many inorganic and organic chemical reactions that produce CL in the 
liquid phase.   However, there are only a few systems that have been used for analytical 
purposes, including luminol ( 5-amnio-2,3-dihydrophathalazine-1, 4-dione), lucigenin 
(N,N-dimethyl-9, 9-biacridinium nitrate), lophine (2,4,5-triphenylimidazole), bis(2,4,5-
tricholorophenyl oxalate), and  luciferin.   Luminol, followed by lucigenin, are the two 
most commonly employed CL reaction. [38, 46, 47]  Because many of the solution phase 
systems use hydrogen peroxide or organic peroxides as oxidants, these can be generated 
in many ways in liquid systems to extend the applicability of CL for analysis.  
Types of Chemiluminescence  
Lminol Chemiluminescence 
Luiminol (5-amino-2, 3 dihydrophthalazine-1, 4-dione) is one of the most 
popular, commonly used, and functional chemiluminescent reagents.  It can produce its 
blue fluorescent under basic condition with an oxidizing agent.  Specifically, lumniol is 
used for the detection of horseradish peroxidase (HPR) using hydrogen peroxide (H2O2) 
as a substrate. [47]   Lumniol is a relatively simple compound and was often used in 
biochemistry for determination of enzymatic reaction as well as in blood detection in 
crime scene.   
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The chemiluminescent emitter is a "direct descendent" of the oxidation of luminol 
or an isomer like isoluminol by an oxidant in basic aqueous solution.  Light is produced 
when luminol reacts with an oxidizing agent to yield an excited singlet state of 
aminonaphthalate anion and emits an intense blue color. [39]  The oxidation of luminol is 
one of the more commonly known non-enzymatic chemiluminescent reactions.  Probably 
the most useful oxidant is hydrogen peroxide.  However, other oxidants have also been 
used such as perborate and permanganate.  It is very stable in the absent of oxygen.  
Figure 5 shows how luminol reacts with hydrogen peroxide with the formation of 
dinegative ion of luminol, which then reacts with oxygen or an oxidizing agent.  Nitrogen 
gas is discharged during the reaction, leaving the luminol in an excited state in the form 
of 3-aminophthalate ion which emits light at a maximum wavelength of 425 nm. [37, 38] 
 
 
Figure 5.  Reaction of Luminol with Hydrogen Peroxide  
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Luminol CL has been shown to be a very sensitive method for the determination 
of metal ions such as Cu2+, Co2+, and Fe2+.  Some of the catalysts that have been used are 
Cu(II), Cr(II), VO2-,  Mn(II), Ni(II), and Co(II) and the co-oxidants are S2O82-, Fe(CN)63-, 
heamine and peroxidase and permangnate are  required for CL.[39, 40, 49] 
When luminol is placed in a basic solution with perborate, permanganate, 
hypochlorite, iodine, or hydrogen peroxide, and a catalyst such as iron, manganese, 
copper, nickel, or cobalt is added, the luminol is oxidized.  A catalyst is the most 
important ingredient to the reaction because the more effective the catalyst the longer and 
brighter the light will glow.  Hydrogen peroxide works best in base, and cobalt has 
proven to be the best metal catalyst.  Some metals, however, repress CL at different 
concentrations and within certain limits.  The CL intensity of luminol is directly 
proportional to the concentration of the oxidant, the catalyst, or the luminol itself. [46, 
47] 
Olsson [48] studied the determination of hydrogen peroxide using CL with a 
reagent consisted of 100 μM of luminol and 3 μM of the peroxidase at pH 10 of 
carbonate buffer.  In his method an automated flow injection system with throughput of 
two samples per minute was used and the linear log-log calibration curve resulted in a 
slope of 1.3 from the detection limits of 3 x 10-9 up to 10-5 M of H2O2.  
The chemiluminescent properties of luminol are remarkable in fact that instead of 
heat, reactions involving luminol produce a cool light that has become a useful tool for 
both scientific community and average individuals.  It has aided research in blood, 
forensic, and chemical analyses.  
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Peroxyoxalate Chemiluminescence (PO-CL) 
Proxyoxalate Chemiluminescene was introduced by Chandross [50] in 1963.   He 
found a very bright CL resulted when he added acid chloride to hydrogen peroxide 
containing a fluorophore such as anthracence and 9, 10-diphenylanthracene or N-
methylacridone.  Later, Rauhut et al. [51] proposed 1, 2-dioxetanedione as a possible 
high energy-rich intermediate and capable of transferring energy to fluorophores in 
POCL reactions.  
POCL reaction is one of the most frequently used CL analytical applications.  It 
has unique properties, which permits many applications that cannot be served by 
electrically powered devices.  For example, in areas where the possibility of explosion 
exists, chemical light can be employed safely; being a cold luminescent source it cannot 
be a source of ignition.  An amazing variety of useful techniques of PO-CL has been 
developed in recent years such as emergency lights for fuse in power failures; small 
portable lights for camping, backpacking, jogging; marking lights for life jackets; lures 
for commercial fishing; and a wide spectrum of novelty uses. [50, 51]  Whereas most CL 
reactions involve emission from a reaction intermediate derived from one of the reagents, 
the peroxyoxalate reaction transfers energy to a variety of fluorescent molecules that in 
turn emit light during relaxation from the first singlet excited state.   
POCL is a chemi-excitation process involving an oxalic acid derivative, usually 
an activated diaryl oxalate.  It is based upon the reaction between hydrogen peroxide with 
an activated oxalate, leading to the formation of one or more energy-rich intermediates, 
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and capable of exciting a large number of fluorphores through the chemically initiated 
electron exchange luminescence mechanisms.  The process is shows in the following 
equations. 
TCPO  +  H2O2                             [C2O4]   +  ArOH    (15) 
[C2O4]   +  Fluorophore                  2CO2   +  Fluorophore*    (16) 
          Fluorophore*                           Fluorophore  +  һυ    (17) 
           
 PO-CL involves three steps.  In the first step, an aryl oxalate ester like bis(2,4,6-
tricholorphenly)oxalate (TCPO) reacts with hydrogen peroxide to produce an  
intermediate 1, 4-dioxetanedione (C2O4).  In the next reaction, the intermediate 
decomposes into carbon dioxide giving its energy to an available fluorophore.  The final 
step is the emission of light energy when the excited fluorophore returns to the ground 
state.  It is evident that H2O2 is essential for CL generation and, therefore, the removal of 
hydrogen peroxide would lead to CL inhibition.  Acidic and basic moderators or other 
catalyst affect the reaction rate of H2O2 with oxalate. [50- 51] 
The oxalate, Bis(2, 4, 6-tricholophenly) oxalate (TCPO) is one of the most 
common aryl oxalate esters used in the chemiluminescent analysis.  Its structure is shown 
in Figure 6. 
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Figure 6. Bis (2, 4, 6-tricholorphenly) oxalate (TCPO) 
Oxalate esters such as TCPO allow production of light from fluorophores when 
reacting with hydrogen peroxide.  To increase the sensitivity, a suitable fluorophore such 
as  perylene is used. [51] This reaction has been successfully used as highly sensitive 
detection in procedures developed for low-level determination of a wide variety of 
analytes.  The reaction can be used for the detection of fluorophore or hydrogen peroxide.  
Additionally, PO-CL can also be coupled with a various instrumentation including flow 
injection analysis (FIA), high-performance liquid chromatography (HPLC) or capillary 
electrophoresis (CE) for the detection of flurophore or fluorescent derivatives.    It has 
been also used to detect analytes that can produce hydrogen peroxides in enzymatic 
reactions. [52-55] 
 PO-CL has many advantages.  It has greater than four orders of magnitude of 
linear dynamic range.  TCPO is a very stable organic compound and is easy to prepare. 
The reaction can occur very stable over a wide range of pH.  But there is one important 
difference between the peroxyoxalate reaction and other CL reactions which involve 
emission from the intermediate itself.  PO-CL involves an energy transfer to a 
fluorophore.  This feature allows peroxyoxalate reaction to be applied to a wide variety of 
analytes.  TCPO has one major disadvantage, it is very insoluble in water, which requires 
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the use of organic solvent such as acetonitrile, dioxane, tert-butanol, and ethyl acetate. 
[54] 
Application of Peroxyoxalate Chemiluminescence 
Over the years, there have been numerous studies on PO-CL that involve the 
hydrogen peroxide oxidation in the presence of a catalyst to analyze various trace 
amounts of fluorphores.  
  Sigvardson et al., [55] used PO-CL detection for many amino-substitution 
polycyclic aromatic hydrocarbon (amino-PAH) in high-performance liquid 
chromatography (HPLC).  They observed the detection limits to be typically one to two 
orders of magnitude lower than those achieved in the same chromatographic system using 
fluorescence detection.   The amino-PAH were selectively detected with high sensitivity.  
Sigvadson and his coworkers believed that the high selectivity of the amino-PAH over 
other fluorescent compounds arose from differences in the excitation step.  The energy 
transfer from the key intermediate to an aromatic amine appeared to be very efficient.   
For most aromatic compounds with no functioned group, the ability to undergo charge 
transfer is most important in the excitation step.   It also had been shown that a linear 
relationship existed between the log of the corrected CL response and the oxidation 
potential when electron transfer mechanism was Nernstian.  
   Arnous and his associates [56] developed a simple, rapid, sensitive, and enzyme-
free analytical method for estimating the scavenging of hydrogen peroxide using 9, 10-
diphenylanthracene as fluorophore.  Aliquot of 1.8 mL of 9, 10-diphenylanthracene was 
mixed with 0.2 mL of imidazole solution (4.5 mM) and 0.025 mL of H2O2 (2.25 mM).   
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The entire sample was mixed with 0.2 mL of TCPO solution (0.45 mM) and 0.05 mL of 
test compound for about 5 s.  The reactions were performed in organic solvents of 
acetonitrile and ethyl acetate (9:1).  The CL signal was found to be linear for H2O2 in the 
concentration range of 9.0 to 72.0 µM.  However, when the reaction was performed in 
acetonitrile only, no satisfactory result was obtained and it was highly unstable.  Using a 
mixture of ethyl acetate and acetonitrile gave excellent linear calibration curve with 0.999 
correlation coefficient. 
Substitutions of the imidazole and other leaving groups have been tested for 
catalytic efficiency in PO-CL reaction using TCPO as reagent.  Catalytic activity was 
discovered for 1,2,4-triazole, 1-methlimidazole, 2-methylimidazole, 4-methylimidazole, 
and 4,5-dichloroimidazoe. [56-57] Derivatives with constituent having only moderate 
influence on the electronegativitiy of the imidazole ring were capable of catalyzing PO-
CL reaction.  However, none of the compounds mentioned above was more efficient than 
imidazole.   The spectrophotometric measurements of the catalytic breakdown of TCPO 
showed that the intermediate was formed with all catalysts, and the stable intermediate 
led to a reduced catalytic efficiency in the PO-CL reaction with TCPO.    Evidently, the 
ability of the imidazole to catalyze the PO-CL reaction of TCPO is largely dependent on 
the ability to destabilize the TCPO reagent.  This is most efficiently done by forming an 
intermediate that is less stable than TCPO, which is then more susceptible to nucleophlic 
attack by hydrogen peroxide. [56-58] 
 Advantages and Limitations of Luminescence Technique
Some of the advantages of molecular emission such as fluorescence, 
phosphorescence, and chemluminescence are their extreme sensitivity, good selectivity, 
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and wide linear range of analysis.   Their extreme sensitivity is the most important aspect 
of luminescence techniques.  The minimal detectable concentration for an assay 
ultimately depends on how sensitively light can be detected and on the quantum 
efficiency (Φ) of the fluorophor.  This sensitivity is because fluorescence signal is 
directly proportional to the concentration of the substance; and the emitted radiation can 
be measured by a photomultiplier tube extremely senstitively. [39]   Absorbance 
measurements can reliably determine concentrations only as low as several tenths of a 
micromolar.  Fluorescence techniques can accurately measure concentrations one million 
times smaller, at pico and even femtomolar level.  Quantities less than an attomole  
(<10-18 mole) can be detected.   
 However, there has been a very little improvement in the selectivity of fluorescent 
measurements by instrumental means.  These limitations include an inherent broad-band 
structure of fluorescenct spectra of many molecules at room temperature.  This limits the 
ability of conventional measurement system to resolve the overlapping bands which are 
often observed in mixtures of fluorescent compounds.  For some molecules, low 
temperature measurement helps to sharpen bands and improve spectral selectivity. [37-
40] 
The specificity of the BL and CL is possible by using luminescence as an 
indicator reaction coupled to the intermediates such as ATP, NADH, and H2O2 which are 
generated during enzymatic reactions.  Because of the enzymatic process, BL reactions 
are very specific.  However, CL reactions are not as specific.  For instance, luminol will 
undergo CL reaction with various oxidants such as oxygen, peroxide, superoxide, and 
iodine, and the reaction is subject to interference by reducing agents. [41] 
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Since CL is an emission process as opposed to absorption, response is usually 
linearly proportional to the concentration from the minimal detectable up to the point 
where it is no longer possible to maintain an excess of other reactants relative to the 
analyte. 
The distinct advantage of CL analysis is the absence of external light source, the 
emission can be measured against a completely dark background.  The only background 
signal is that of the PMT’s dark current.  Therefore, light source warm-up drift and 
interference from light scattering are absent.  In systems where red and near infrared light 
are observed in analytical detection, red sensitive PMT's dark current can be minimized 
by cooling; with blue light emission detection, cooling is not required.   Thus methods are 
highly sensitive because of low light level monitored in the absence of noise. Detection 
limits is orders of magnitude lower than fluorescence methods. [39-40]    The detection 
limits can be the range of femtomole.  For instance, in liquid phase down to 1 fmole of 
the fluorophore may be detected using PO-CL system and 0.10 fmole peroxidese when 
using luminol. [39]  However, the detection limits of the CL are determined by the 
reagents purity rather than by the transducer sensitivity.  CL is 105 times more sensitive 
than absorption spectrometry and at least 103 times more sensitive than fluorimetry.  
Flow Injection Analysis (FIA) 
   In the mid-70s, flow injection analysis (FIA) became a popular powerful 
analytical technique for analysis.  It was introduced and developed by Ruzicka and 
Hansen [60] from Denmark and Stew from United States.  It  is based on the injection of 
a liquid sample into a moving, non-segmented continuous carrier stream of a suitable 
liquid.  The injection sample forms a zone that is transported toward a detector that 
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records the absorbance, electrode potential, or other physical parameter as it changes due 
to the passage of the sample through the flow cell.    
The flow injection analyzer consists of a pump that is used to propel the carrier 
stream through a narrow tube; an injection port that introduces reproducibly a well-
defined volume of a sample solution into the carrier stream; and a micro-reactor in which 
the sample zone disperse and reacts with the component of the carrier stream forming a 
species that is sensed by a detector and recorded. 
FIA [61] is based on the combination of three principles: sample injection, 
controlled dispersion of the injection sample zone, and reproducible timing of its 
movement from the injection point toward and into the detector.  The chemical analyses 
are taking place while the sample material is dispersing within the reagent, that is, while 
the concentration gradient of the sample zone is being formed by the dispersion process.  
FIA also is potentially a useful technique for field operation due to its portability, 
flexibility, and low cost.  Photomultiplier tubes (PMT) requiring a high voltage power 
supply have traditionally been used for detecting the CL emission.  However, low voltage 
(12V), low power PMT and solid state detector like photodiodes array detector have also 
been used for monitoring total CL emission.  
FIA has the advantages of very low sample reagent consumption.  The small 
volume of the flow cell prevents excessive dilution.  The signal is highly reproducible 
because the signal is acquired as a narrow peak and corresponds to the portion of analyte 
passing through the cell.  FIA is now well established as an excellent technique for rapid, 
automated, quantitative analysis that can perform on-line chemical and physical sample 
treatment with flow through detection in an enclosed and continuous flow environment.  
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It is particularly well-suited to monitoring transient light emission from liquid phase CL 
reaction due to the rapid and reproducible mixing of sample and reagents in close 
proximity to the detector. 
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CHAPTER 4 
METHODOLOGY AND EXPERIMENTAL PROCEDURE 
Cholesterol determination is very important in clinical diagnosis because high 
levels of cholesterol are associated with the risk factor of heart disease, arteriosclerosis, 
and hypertension. [3, 4]  As a result, intensive research efforts have been made to 
understand the properties of cholesterol and to find ways for lowering cholesterol levels.  
Normally, cholesterol is also partly present in an esterified form and the proportion [4] by 
weight of esterified to free cholesterol in the body is about 60:40.  This means analytical 
determination of cholesterol in food products is important. 
 As shown before, various analytical methods have been used for the 
determination of free cholesterol.  Most methods now involve enzymatic procedures 
because of their rapidity, selectivity, sensitivity, and greater accuracy.   They are based on 
the hydrolysis of cholesterol ester to free cholesterol that is then oxidized in the presence 
of cholesterol oxidase (COD) to produce cholest -4-ene-3-one and hydrogen peroxide.  
After this, various methods can be devised to measure the amount of hydrogen peroxide. 
Proposed Research 
The aim of this research project is to develop a flow injection analysis procedure 
based on the peroxyalate chemiluminescent detection, or FIA-POCL, of the hydrogen 
peroxide produced by enzymatic reaction of esterified and free cholesterol in the presence 
of cholesterol esterase and cholesterol oxidase to determine the total cholesterol level in 
foods.  The proposed reaction scheme is shown Figure 8 
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Figure 7. Reaction Scheme for FIA-POCL Analysis of Cholesterol based on Enzymatic  
   Cholesterol esterase (CE) and cholesterol Oxidase (COX) and CL Procedures 
  
Objectives of the Proposed Research 
 The objectives of the proposed research are as follow: 
1. To develop a sensitive and economical method for the analysis of total cholesterol in 
foods. 
2. To use enzymatic methods to confer selectivity and chemiluminescence detection to 
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enhance sensitivity of analysis.  
3. To designed a flow injection system for rapid and reproducible measurements.     
4. To evaluate the validity of the method, figures of merits such as precision, accuracy, 
and linearity will be assessed. 
5. To apply the proposed procedure to the analysis of total cholesterol in commercial 
products.  These samples including commercially available butter, cheeses, lard, 
chicken fat, and beef fat.  
Experimental Procedure 
Reagents 
 Cholesterol standard (200 mg/dL) in a buffered aqueous solution of cholesterol 
with stabilizers, surfactants, and preservative was obtained from Stanbio Laboratory (Fort 
Worth, TX). 
Cholesterol oxidase, 250 U, cholesterol esterase 100 U, Sigma (St. Louis, MO). 
Cholesterol (98%), Imidazole, 99 %, Aldrich Chemical Company (Milwaukee, 
WI)  
Triton-X-100, Eastman Kodak Company (Rochester, NY).  
Hydrogen peroxide 30%, ethanol 95%, methanol, ethanol, ethyl ether, petroleum 
ether, isoproprly alcohol, acetonitrile, potassium hydroxide, glacial acetic acid, 
concentrated sulfuric acid, acetic anhydride, di-sodium phosphate, potassium dihydrogen 
phosphate, methylene chloride, and sodium salt of cholic acid, all ACS reagent grade, 
Fisher Scientific (Fair Lawn, NJ) were used as received. 
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 Bis (2,4,6 tricholorophenyl)oxalate (TCPO) was synthesized in the laboratory by 
the method of Mohan and Turro. [62] 
Stock Solutions 
 The following stock solutions are prepared for long-term storage from which 
working solutions are made.  
1. Cholesterol stock solution A (9.99 mg/mL).  Prepared by dissolving 0.2489 g of 
98 % cholesterol with 2-propanol in 25-mL volumetric flask.  
2. Cholesterol oxidase (COX) (2.06 U/mL), dissolved 250 units of cholesterol 
oxidase with pH 7.0 phosphate buffer with 50 μL of Triton X-100 added, and the 
solution diluted to the mark in a 100-mL volumetric flask.   
3. Cholesterol esterase (CE) (1 U/mL), dissolved 100 unit of cholesterol esterase 
with phosphate buffer with 50 µL of Triton X-100 added, and the solution diluted 
to the mark in a 100-mL volumetric flask.  
4. Perylene (1.86 x 10-4 M), dissolved 0.0047 g in acetonitrile and diluted to 100 mL 
in a volumetric flask.   
5. Imidazole solution (100 mg/mL):  prepared by dissolving 1 g of imidazole in  a 
10-mL volumetric flask and diluted to the mark with pH 7.0 phosphate buffer. 
6. Phosphate buffer, pH 7.0 (0.20 M), dissolved 0.9422 gram of disodium 
phosphate, and 1.57 gram of potassium di-hydrogen phosphate in 200 mL of 
deionized water.   
7. Sodium of cholic acid (129.6 mg/mL), prepared by dissolving 1.296 g of sodium 
cholate salt in 10 mL of phosphate buffer.  This solution was made fresh daily.    
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8. 30 % Hydrogen peroxide was used as provided and was stored in its original 
plastic bottle in the refrigerator. 
Working Solutions  
Cholesterol working solution, 0.9992 mg/mL was prepared from the stock 
solution B by dissolving 1.0 mL of stock standard cholesterol and diluted with 2-propanol 
to the mark in a 10-mL volumetric flask.   
Hydrogen peroxide, 3%, was freshly prepared by diluting 1 mL of the 30 % H2O2 
in deionized water in 10-mL volumetric flask.  
TCPO, (1.20 mg/mL), was prepared by dissolving 0.120 g of TCPO in 100 mL of 
acetonitrile with sonication for 45 minutes. Any unused solution was stored in brown 
glass bottle in the refrigerator.    
The color reagent for spectrophotometric measurements was prepared by 
dissolving 50 mg of 4-aminophenazone, 100 mg of phenol and 1 mg of peroxidase per 
100 mL of 0.4 M sodium phosphate pH 7.0 buffer.   It was stored in amber colored bottle 
before use at 4 oC and prepared freshly every week. [64] 
Instrumentation 
The CL signals were monitored by an American Instrument Company 
microphotomer (Silver Spring, MD), with a Hamamatsu R928 photomultiplier tube 
mounted in front of the home made flow cell of about 90 μL in volume.  The CL signals 
were recorded with the Model 680 Hewlett-Packard, Strip chart recorder.   Cole Parmer 
Master Flex peristaltic pump (Barrington, IL) was used to pump reagent solution at 1 
mL/min.  
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 Rheodyne 7125 injector with 20-µL sample loop (Cotati, CA) was used to 
introduce the sample into the flowing stream. 
Figure 9 is the schematic diagram of the FIA-POCL system for  cholesterol 
determination.  The TCPO / perylene solution is pumped at the rate of 1.0 mL/min by the 
Cole-Palmer Master Flex peristaltic pump.  Aliquots of samples were injected into the 
Rheodyne 7125 injector 20-µL sample loop using a 100-µL syringe.  The mixtures pass 
through the home-made flow cell where the photomultiplier tube measured the CL 
intensity emitted.   The signals were processed by the American Instruments micro-
photometer and also recoded on the Hewlett Packard strip chart recorder. 
   
Figure 8.   Instrumentation of FIA-POCL system for CL intensity measurements   
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Preparation of Cholesterol Calibration Standard Solutions  
  From the cholesterol standard working solution (9.9992 mg/mL),  a more dilute 
working solution of 0.9992 mg/mL was prepared by pipetting 1-mL of 9.9992 mg/mL 
solution into a 10-mL volumetric flask and diluting to the mark with 2-propanol.  
Calibration working solutions were then prepared by pipetting 50, 100, 200, 400, and 600 
µL into 5-mL volumetric flasks.   Into each flask 250 µL cholesterol esterase, 500 µL 
cholesterol oxidase and 500 µL sodium cholate were added.   After mixing, the samples 
were incubated for 30 min at 37–40 oC in a water bath.  Addition of 100 µL of imadazole 
solution followed the incubation period and the mixtures were finally diluted to the mark 
with pH 7.0 of phosphate buffer.   These samples were then ready for CL measurements. 
Preparation of Solutions for Optimization of Imidazole 
 To determine the optimum amount of imidazole used, the following solutions 
were made.  Into each 10- mL volumetric flask 100 µL of cholesterol working solution 
(0.9992 mg/mL), 500 µL cholesterol oxidase   (2.06 U/mL), and 250 µL cholesterol 
eastrase (1.0 U/mL) were mixed in the flask.  The mixtures were incubated for 30 
minutes in a water bath of 37-40 0C.  The addition of imidazole was made right after the 
incubation period.  The different amounts of imidazole added were 1, 5, 40, 100, 250, and 
500 μL respectively.  Finally, each flasks were diluted to the mark with pH 7.0 phosphate 
buffers and were ready for CL measurement.  
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Preparation of Hydrogen Peroxide Solutions for Linearity Studies  
To determine the linearity of CL with hydrogen peroxide, five different 
concentrations of hydrogen peroxide were prepared in 10-mL volumetric flasks.   Into 
five different flasks 50, 100, 150, 200, and 250 µL of 3% hydrogen peroxide working 
solution were pipeted, respectively.  To all the flasks 100 µL imidazole solution was 
added and finally the solutions were diluted to the mark with phosphate buffer.  These 
samples were then ready for CL measurement.  
Preparation of Solutions for Reproducibility Studies 
The solutions for these experiments were prepared in two ways.  The first 8 
solutions were made using the standard working cholesterol solution (0.9992 mg/mL).  
Into each 5-mL volumetric flasks, 100-µL aliquots of working cholesterol were pipeted.  
Then into all the flasks, 250 µL cholesterol esterase, 500 µL cholesterol oxidase, and 500 
µL of sodium cholate were added.  The mixtures were incubated at 37-40 oC in a water 
bath for 30 min.   After incubation, 100 µL of imidazole solution were added as a catalyst 
and the mixtures diluted to the mark with pH 7 phosphate buffer.  The samples were now 
ready for CL measurements.   
The second set of experiment was performed using a butter sample to determine 
the reproducibility of the proposed procedure.  Eight aliquots of 100 µL of working butter 
sample were pipeted into 5-mL volumetric flasks.  Then 250 µL cholesterol esterase, 500 
µL cholesterol oxidase, and 500 µL of sodium cholate were added.   The mixtures were 
incubated at a 37-40 oC in a water bath for 30 minutes.  After incubation 100 µL of 
imidazole solution were added to the mixture and diluted to the mark with the phosphate 
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buffer.  The samples were then ready for CL measurement. 
Preparation of Solutions for the Recovery Studies 
To determine the accuracy of the proposed method, recovery studies were 
performed.   A calibration curve and a series of spiked samples were prepared.  Five 
standard cholesterol working solution ranging from 0.0100 to 0.1199 mg/mL were 
prepared as described for use in constructing a calibration curve.  Aliquots of 500 µL 
standard commercial cholesterol (2 mg/mL) were pipetted into nine 5-ml volumetric 
flasks.  Into all flasks, 250 µL cholesterol esterase, 500 µL cholesterol oxidase, and 500 
µL sodium cholate were added.   The mixtures were then divided into three group 
triplicates.  For the first triplicate, no standard cholesterol working solution was added, 
while 100 µL and 200 µL of standard cholesterol working solution were added, 
respectively, to the second and third triplicates.  Then the mixtures were incubated for 30 
minutes at 37-40 oC.  Finally, 100 µL of imidazole solution were added to the mixtures 
and diluted to the mark with pH 7 phosphate buffer.  The samples were then ready for CL 
measurement.  
Another set of experiments was conducted to determine the recovery of the 
proposed FIA-POCL method using the butter sample (2 mg/mL).   The same procedure 
was used to prepare the butter samples for the recovery studies except that the butter 
samples were spiked with 200 μL and 400 µL of standard cholesterol working solution 
(0.9992 mg/mL) for the second and third triplicates respectively.  
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Preparation of Consumer Samples for Analysis 
Diverse samples were chosen to be determined for their cholesterol content using 
the proposed FIA-POCL method.   An extraction procedure to extract the free cholesterol 
was tried at first.  Cholesterol was extracted with 50 mL of a freshly prepared methanolic 
2 M potassium hydroxide for two hours.  The warmed mixtures were transferred into a 
200-mL separating funnel.  After the mixture had cooled down to room temperature, 100 
mL of 1:1 (v/v) petroleum ether and ether were added and mixed very well.  The organic 
phase was allowed to separate for 30 minutes.  The clearly separated lowered organic 
phase was drained off and the extraction process was repeated.  The organic phase 
solvent was evaporated on a rotary evaporator and the resulting solution was kept in the 
refrigerator.  The residue obtained was redissolved by the same procedure as was used to 
prepare the standard cholesterol solution. The sample was made in methylene chloride.   
However, the extraction process did not seem to work well and so the procedure was 
abandoned.  It was too time-consuming, contamination and loss of sample seemed to be 
major problems.  Instead, for all subsequent determinations, the samples were prepared 
without the extraction procedure and better results were obtained.  Samples such as beef 
fat, chicken fat, butter, and a number of cheeses such as Italian and sharp cheddar were 
used.  Approximately 0.25 gram of samples were dissolved in 25 mL of 2-propanol (10 
mg/mL).   Further dilution had to be made because 10 mg/mL of samples caused 
precipitation to occur when other reagents were added.   Therefore, 1-mL of each sample 
was diluted into 10-mL with 2-propanol to give a final working solution of 1-mg/mL 
concentration.  Then for experiments, 500 µL and 1000 µL of the diluted food samples 
were pipetted into 5-mL volumetric flasks, and then 250 µL cholesterol esterase, 500 µL 
cholesterol oxidase, and 500 µL sodium cholate were added to them.  The solutions were 
 66
incubated for 30 minutes at 37-40 oC and 100 µL of imidazole solution added after 
incubation.   Finally, the mixtures were diluted to the mark with the pH 7 phosphate 
buffer.  The samples were then ready for CL measurement. The same procedure was used 
for all types of samples.  However, for beef fat, chicken fat, and lard, 1.0 g of the stock 
sample was dissolved in 25 mL of 2-propanol from which the working solutions were 
made the same way as other samples.  Theses samples had to be prepared daily and 
stored in the refrigerator.     
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CHAPTER 5 
RESULTS AND DISCUSSION 
The results of all the experiments on optimization and validation of the proposed 
analytical method were tabulated and discussed in this chapter.  These experiments were 
conducted to evaluate the linear dynamic range, detection limits, precision, and accuracy 
of the proposed methods. 
Analytical Figures of Merit 
 
 The performance and reliability of the proposed methods were assessed by 
determining the important analytical figures of merit: linearity range, reproducibility, or 
precision (as relative standard deviation, RSD) and the recovery or accuracy of the 
methods.  The proposed procedure was also compared with a well established method to 
assess its validity.   
Effect of Surfactants 
Various surfactants have been used to enhance CL signal.  The effect of several 
surfactants on CL signal was examined in this study.   The results indicated that anionic 
surfactants such as sodium dodecylsulfate (SDS) had a slight quenching effect on the 
proposed procedure.  The measured CL signal was very weak when SDS was added to 
the solution versus the non ionic surfactant Triton X-100 which improved the CL signal.  
Triton X-100 is often used as a lipid solubilizing agent.  The amounts of the surfactants 
added must be adjusted carefully because the solubility of the lipid and the activity of 
enzyme were affected by the amount of the surfactant present.  It was found that 100 µL 
of Triton X-100 must be added to the incubation mixtures of cholesterol oxidase and 
cholesterol esterase and cholesterol sample to improve the solubility of cholesterol.  
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Sodium cholate is also another important surfactant used in this experiment.   Based on 
the results obtained, adding 500 µL sodium cholate (1.29 mg/mL) to the incubation 
mixtures improved the CL signal.  Being a lipid solubilizer, the surfactants help to 
prevent cholesterol from precipitating out in the presence of aqueous reagents.  
Optimization of Imidazole  
Imidazole, a base, has been recognized as an excellent catalyst for TCPO and 
hydrogen peroxide reaction.  For the FIA- POCL reaction the amount of imidazole used 
was varied to determine the optimum concentration of imidazole to obtain the highest CL 
signal.  
   Several 100-µL aliquots of standard cholesterol working solution, 250 µL 
cholesterol esterase, 500 μL cholesterol oxidase, and 500 μL of sodium cholate were 
pipetted into different 10-mL volumetric flasks.  The solutions were incubated for 30 
minutes in a 37 – 40 0C water bath.   After incubation 1, 5, 10, 40, 100, 250, and 500 μL 
of imidazole stock solution (100 mg/mL) were added into the volumetric flasks 
containing the cholesterol mixtures and diluted to the mark with pH 7.0 phosphate buffer.  
The results of the experiment are tabulated in Table 3.  The CL signals were the average 
of three injections.  These results were also plotted in Figure 10. 
 
Table 3.   Results of Optimization of Imidazole Concentration for FIA-POCL Reaction  
Volume (µL) of Stock 
imidazole Solution 1.0 5.0 10.0 40.0 100.0 250.0 500.0 
CL Intensity 0.011 0.028 0.051 0.094 0.289 0.420 0.211 
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Figure 9.  Plot of the results of the optimization experiment of volume of imidazole  
Stock solution to be used as catalyst for FIA-POCL reaction  The concentration     
of the stock imidazole solution was 100 mg/mL.   
 
The results showed that CL intensity increased with the amount of imidazole used 
up to a certain value.  The maximum CL intensity occurred when 250 µL of stock 
imidazole solution was added.  Based on the results the optimum amount of imidazole for 
the proposed method was chosen to be 200 μL of stock imidazole solution even though 
the maximum signal was at the 200-250 µL range.  The 200 μL of imidazole used 
correspond to a concentration of 0.50 mg/mL in the mixture.  As one increased the 
concentration of imidazole, the CL reaction may proceed at such a rate that the CL signal 
may have vanished by the time the reagents reach the flow cell for measurement.  
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Moreover, it was observed that excess amount of imidazole could lead to the precipitation 
of cholesterol.   
Linearity Studies of CL signal with Concentration of Hydrogen Peroxide  
It is well known that hydrogen peroxide is enzymatically generated by reactions 
of various oxidases.  Sensitive and selective methods for hydrogen peroxide 
determination have been a requisite in biological or biomedical chemistry.  A wide 
variety of CL reactions exists and many of these have been employed for the 
determination of hydrogen peroxide.   Hydrogen peroxide acts as an oxidant in the 
reaction with TCPO and the oxidation provides the excitation energy for CL.  
 The CL signal was measured by varying the concentration of H2O2 reacting with 
fixed amounts of TCPO and imidazole at a given flow rate.  The results of the linearity 
study of CL with hydrogen peroxide concentration is tabulated in Table 4 and also plotted 
in Figure 10.       
 
Table 4.  Result of Linearity Study of CL Intensity with Varying Hydrogen Peroxide  
               Concentrations 
 
H2O2 (M) 0.0009 0.0018 0.0026 0.0035 0.0044 
CL Intensity 32.0 47.0 60.3 72.0 80.0 
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Figure 10.  Plot of CL signal with varying hydrogen peroxide concentrations.  The  
      CL Intensity is given in arbitrary units 
 
 
The Calibration curve was linear for hydrogen peroxide concentration from        
9.0 x 10-4 M to 4.4 x 10-3 M.  The equation of the regression line was Y = 13886.42x + 
21.60 with correlation coefficient of 0.99.  These result showed that CL intensity 
increases linearly as we increase the concentration of hydrogen peroxide.  The data 
indicated that the linear dynamic range was wider than the concentration range of 
hydrogen peroxide used in the study. 
 
Reproducibility Studies 
 
 For a proposed method to be useful and applicable for analysis, the analytical 
method has to be reproducible.  Additionally, the proposed procedure has to have about 
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the same precision as the established reference method.  To evaluate the reproducibility 
of the proposed procedure, two sets of experiments were performed.  One set was 
conducted using the standard cholesterol solutions prepared in our laboratory.   The 
second set was conducted on the commercial butter samples to determine the 
reproducibility of the measurement and the variability of the commercial item. 
For the first set, eight 100-µL aliquots of standard cholesterol working solution of 
concentration 0.9992 mg/mL, 250 µL cholesterol esterase, 500 µL cholesterol oxidase, 
and 500 μL sodium cholale  (129.6 mg/mL) were pipetted into 5-mL volumetric flasks.  
The mixtures were incubated for 30 minutes at 37-40 oC to produce the hydrogen 
peroxide.  Then 100 μL of imidazole were added to the mixtures and the solutions finally 
diluted to the mark with pH 7 phosphate buffer.  The final concentration of cholesterol in 
all the solutions was 0.01998 mg/mL.  CL measurements were then made by injecting the 
resulting mixture into the 20-µL loop of the FIA system containing a flowing stream of 
1.20 mg/mL TCPO with 3μL/mL of perylene in acetonitrile.   The results of the 
experiment are tabulated in Table 5. 
 
Table 5.   Results of the Reproducibility Study of the Proposed FIA-POCL Method Using  
    Standard Cholesterol Solution. Final Concentration of 0.020 mg/mL 
 
Trial 1 2 3 4 5 6 7 8 
CL Intensity 0.330 0.343 0.336 0.329 0.329 0.331 0.313 0.333 
Average CL Intensity 0.330, (0.024 mg/mL, +2.0%) 
Relative Standard Deviation 2.57 % 
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From the data obtained the mean of eight CL measurements was 0.330, with a 
relative standard deviation of 2.57 %.  The results were within experimental error and 
demonstrated that the precision of the proposed analytical procedure was satisfactory.   
The second study was conducted using a commercial butter bought from a local 
store.  The butter samples were prepared without any extraction procedure.  Butter 
samples weighing 0.25 g each were dissolved in 25 mL of 2-propanol giving a final 
concentration of 10 mg butter/mL.   Then 1-mL aliquots of the dissolved butter sample 
were pipetted into eight 5-mL volumetric flasks.  Then, as described before, the same 
incubation procedure and FIA-POCL measurement was carried out. The final 
concentration of the mixtures was 2 mg butter/mL solution.  The experimental results are 
tabulated in Table 6.   
 
Table 6.   Results of the Reproducibility Study of the Proposed FIA-POCL Method Using 
    Butter Sample 
 
Trial 1 2 3 4 5 6 7 8 
CL Intensity 0.310 0.316 0.322 0.320 0.317 0.333 0.316 0.322 
Average CL Intensity 0.320 
Relative Standard Deviation 2.11 % 
 
 
For the data obtained, the mean CL intensity for the eight aliquots of the butter 
sample was 0.320 with a relative standard deviation of 2.11 %.   These results showed 
that the proposed procedure was reproducible for both pure standard cholesterol solution 
and the cholesterol present in samples like butter.  
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Linearity Studies of the Proposed Method on Cholesterol Samples 
To determine the linearity of our proposed procedure for cholesterol 
determination, two different experiments were done. The first one was described earlier 
indicating CL signals was linear with hydrogen peroxide concentration.  The second one 
to be described below is to show the linearity of CL intensity with standard cholesterol 
concentration.  For this, a series of standard cholesterol solutions were pipetted into 5-mL 
of volumetric flasks.   As described before, the same incubation procedure and FIA-
POCL measurement were carried out.  The results of the study are tabulated in Table 7 
and the plot shown in Figure 12.  Each datum is an average of triplicate injections. 
 
 
 
Table 7.  Results of the Linearity Study of the Proposed FIA-POCL Method on CL  
    Intensity and Cholesterol Concentrations   
 
Cholesterol Concentration  
(mg/mL) 0.01 0.02 0.04 0.08 0.12 
CL Intensity 0.128 0.281 0.540 1.20 1.80 
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Figure 11.  Plot of CL intensity versus Standard Cholesterol Concentration of 0.010 to  
      0.119 mg/mL  The correlation coefficient for the line was 1.00  
 
The plot shows a linear range of 10-120 µg/mL with a correlation coefficient of 
1.00.  The regression line is given by y = 15.29x - 0.04.  These results indicate that there 
is a linear relationship between the CL signal and the standard cholesterol concentration 
for the proposed method.  The upper range of the cholesterol concentration is limited by 
the solubility of cholesterol in the FIA system.   The lower limit of quantifiable detection 
is about 5 µg/mL of cholesterol. 
Recovery Studies 
To determine the accuracy the proposed procedure, recovery studies were 
conducted.   In these studies, two experiments were done to confirm the results.  In each 
experiment, three sets of triplicate samples containing fixed amounts of commercial 
cholesterol standard samples, or purchased butter, were pipetted into each set of nine 
different 5-mL volumetric flasks.  Then three different triplicates, but known amounts of 
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cholesterol working solution (0.9992 mg/mL) were added to them.  To each of the spiked 
samples, 250 μL cholesterol esterase, 500 μL cholesterol oxidase, and 500 μL sodium 
cholate were added as described before, incubated, treated, and CL measurements made 
to determine the amount of cholesterol added to the samples.  The recoveries of the 
spiked amount of cholesterol added to the samples were calculated based on the 
following equation: 
 
The results of the recovery studies of the proposed FIA-POCL method first using 
the commercial standard cholesterol samples are tabulated in Table 8, and that using the 
purchased store butter are shown in Table 9. 
Table 8.   Results of the Recovery Study of the Proposed FIA-POCL Method on  
     Commercial Standard Cholesterol Samples (0.10 mg) 
 
Sample  CL Signal 
Cholesterol 
Standard added 
(mg ) 
Total cholesterol 
Found 
(mg ) 
% Recovery
1 3.20 0.000   
2 3.20 0.000   
3 3.20 0.000   
4 5.93 0.100 0.101 100.9 
5 6.00 0.100 0.103 103.3 
6 5.93 0.100 0.101 100.9 
7 8.80 0.200 0.195 97.5 
8 8.80 0.200 0.195 97.5 
9 8.81 0.200 0.195 97.5 
Mean Recovery 99.6 % 
Relative Standard Deviation 2.44 % 
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The result of these studies showed that the recoveries of added pure standard 
cholesterol ranged from 97.5 to 103.3 % in commercial standard cholesterol samples, 
while that in butter were found to be in the range from 101.5 to 108.0 %.  It is interesting 
to note that for the butter samples the recoveries were all over 100% and that the 
precision for butter was better (RSD of 1.5%) than using the commercial standard 
cholesterol samples (RSD of 2.44%).  However, the results indicate that the proposed 
method has acceptable precision and recovery, and that the type of sample does not 
significantly affect the recovery. 
Table 9.  Results of the Recovery Study of the Proposed FIA-POCL Method on Butter 
   Samples (0.50 mg/mL) 
 
Sample  CL Signal 
Standard Cholesterol 
Added 
(mg ) 
Total Cholesterol 
Found 
(mg ) 
% 
Recovery 
1 1.00 0.000   
2 1.00 0.000   
3 1.00 0.000   
4 6.20 0.200 0.206 103.0 
5 6.13 0.200 0.203 101.5 
6 6.33 0.200 0.211 105.5 
7 12.00 0.400 0.431 108.0 
8 11.63 0.400 0.417 104.3 
9 11.67 0.400 0.418 104.5 
Mean Recovery 104.5% 
Relative Standard Deviation 1.5% 
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Analytical Applications 
The proposed CL method was applied to the determination of cholesterol present 
in different food products with high level of cholesterol such as cheeses, butter, lard and 
beef and chicken fat.  These samples were prepared as described in the previous chapter 
and no extraction was used.  Also for comparison purposes, a well established enzymatic 
colorimetric method reported by Malike and Pundir  [62] was also performed in parallel 
with the proposed FIA-POCL method for the determination of cholesterol in most of the 
same food samples.  The reported method involved an enzymatic reaction step that was 
followed by a reaction to produce a colored product whose absorption was measured, 
instead of measuring the CL signal after the enzymatic reaction.  
For the colorimetric procedure, the food samples and standard cholesterol 
solutions of various amounts were mixed with, as described before, 250 µL of cholesterol 
esterase, 500 µL of cholesterol oxidase, and 500 µL of sodium cholate in different 
volumetric flasks.  However, the mixtures were incubated for only 5 minutes at 37 – 
40oC.  Then 1.0 mL of color reagent was added.  The color reagent was prepared by 
mixing 50 mg of 4-aminophenazone, 100 mg of phenol, and 1 mg of peroxidase enzyme 
per 100 mL of phosphate buffer.  The mixtures were further incubated for 20 minutes to 
generate a highly colored quinoneimine dye whose absorbance was measured at 520 nm. 
The sample stock solutions were the same.  For the colorimetric method reaction, 
500 µL and 1000 µL aliquots of the working solution of food samples were also used.  
Into 5-mL volumetric flasks, 500 μL cholesterol oxidase, 250 μL cholesterol esterase, 
and 500 μL sodium cholate salt were added to the food samples, mixed, and incubated for 
five minutes.  Then 1.0 mL of the color reagent was added to each flask, diluted to the 
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mark with phosphate buffer, and further incubated for 10 minutes for color production.  
Finally the absorbances of the solutions were measured at 520 nm.  
     Table 10 shows the collected data for the construction of the calibration curve for 
the enzymatic colorimetric determination of cholesterol in food products. The results 
were obtained from the mean of triplicate injections.  The regression line has the equation 
y = 1.93x + 0.001 with a correlation coefficient of 0.997 and the plot is shown in Figure 
14.  The regression equation is then used to determine the amounts of cholesterol in 
various samples as shown in Tables 11, 12, and 13. 
 
Table 10.   Absorbances of Standard Cholesterol Solutions for the Calibration Curve 
      of Cholesterol Determination Using the Enzymatic Colorimetric Method  
 
Cholesterol Standard (mg) 0.010 0.050 0.100 0.150 
Absorbance 0.016 0.099 0.202 0.284 
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Figure 12.  Plot of Absorbance Versus Standard Cholesterol Concentration (mg/mL) for  
       the Enzymatic Colorimetric Method 
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Table 11.   Results of the Enzymatic Colorimetric Determination of Cholesterol For 
      Commercial Cholesterol Standard and Butter 
  
 Absorbance  (AU) 
Cholesterol 
 Found (mg) 
Cholesterol 
Found (mg/g) 
Commercial Cholesterol 
Standard (2.0 mg/mL)    
10 µL (0.02 mg) 0.037 0.017 (-15 %) 
  0.037 0.017 (-15%) 
  0.039 0.018 (-10%) 
Butter 
(1.0 mg/mL)       
200 µL (0.20 mg) 0.037 0.017 8.5 
  0.036 0.016 8.0 
  0.039 0.018 9.0 
250 µL (0.25 mg) 0.042 0.019 7.6 
  0.040 0.018 7.2 
 0.041 0.018 7.2 
Mean (mg/g) = 8.11          Relative Standard Deviation = 8.53 % 
 
 
 
Table 12.   Results of Enzymatic Colorimetric Determination of Cholesterol in Butter 
 
Volume of Butter 
Sample (0.50 mg/mL) 
Absorbance 
(AU) 
Cholesterol 
 Found (mg) 
Cholesterol Found 
(mg/g) 
500 0.106 0.055 11.0 
 0.108 0.056 11.2 
 0.106 0.055 11.0 
1000 0.21 0.108 10.8 
 0.211 0.109 11.0 
 0.212 0.109 10.9 
Mean (mg/g butter) = 11.0     Relative Standard Deviation = 0.90% 
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Table 13.  Results of Enzymatic Colorimetric Determination of Cholesterol in Italian and  
      Cheddar Cheese 
 
Cheese (µL) Absorbance (AU) 
 Cholesterol 
Found (mg) 
Cholesterol Found 
(mg/g) 
Italian Cheese    
500 0.092 0.047 9.4 
 0.093 0.048 9.6 
 0.095 0.049 9.8 
1000 0.159 0.082 8.2 
 0.161 0.083 8.3 
Mean = 9.1 mg/g cheese     Relative Standard Deviation = 8.3% 
Cheddar Cheese       
500 0.09 0.046 9.2 
 0.086 0.044 8.8 
 0.088 0.045 9.0 
1000 0.148 0.076 7.6 
 0.155 0.080 8.0 
Mean = 8.5 mg/g cheese     Relative Standard Deviation = 8.1% 
 
 
Tables 11, 12, and 13 show that the amounts of cholesterol obtained in the 
different types of samples using the enzymatic colorimetric methodology were quite 
consistent.  Also, for the commercial cholesterol standard sample, the results are reported 
slightly differently in that the expected values were known.  So the last column for it 
reports the % error of the value obtained relative to the expected value.  Also in Table 11, 
the results for the same butter sample taken in different amounts for analysis gave notable 
different results with the larger volume samples gave lower values.  Although within the 
same set of volumes, the results agreed well with one another.  This could be due to 
pipeting error as the micro-pipeter had been found to suck up somewhat different 
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volumes unexpectedly.   In Table 12, using a different butter sample, 500 μL butter 
sample gave a result of 11.1 mg cholesterol /g butter while 1000 μL gave about 10.9 
mg/g.   The results are now more consistent as can be seen with the 0.90% RSD. 
  The same procedure was performed for the cheeses samples whose results were 
tabulated in Table 13.   The results of using 500 μL of the cheese sample give the mean 
amount of 9.6 mg cholesterol/g cheese.  However the 1000 μL solutions gave only the 
mean of 8.3 mg/g in Italian cheese.  Cheddar cheese also showed similar discrepancy.  
For the 500 μL the mean results were 9.0 mg cholesterol /g cheese, but for the 1000 μL 
solutions a lower cholesterol amount of 7.8 mg cholesterol/g cheese were obtained.  No 
good explanation for these discrepancies exists other than to suggest that the pipets were 
not in calibration.  In the future this needs to be carefully taken into consideration. 
After the food samples cholesterol content were determined by the colorimetric 
method, the samples were subjected to determination by the proposed FIA-POCL 
method. The results obtained using the colorimetric and the proposed FIA-POCL 
methods have shown fairly similar results and had satisfactory agreement with each 
other.   The results for the same butter and cheese samples using the proposed FIA-POCL 
method are tabulated in Tables 14 and 15.  The values given are the mean of triplicate 
injections. 
A calibration curve was first prepared using the standard cholesterol working 
solution with cholesterol standards of concentration of 0.02, 0.05, 0.08, and 0.120 mg/mL 
were obtained.  The calibration curve shows a straight regression line with the equation 
of y = 14.538x – 0.0855 and correlation coefficient of 0.9929.   
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Table 14.   Results of the Proposed FIA-POCL Method Determination of Cholesterol in  
       Butter 
 
Butter (µL) CL Signal Cholesterol Found (mg/mL) 
Cholesterol Found 
(mg) 
Cholesterol  
Found (mg/g) 
500 0.10 0.013 0.0638 12.76 
500 0.10 0.013 0.0638 12.77 
1000 0.21 0.020 0.0999   9.99 
1000 0.21 0.020 0.1006 10.10 
Mean (mg/g) = 11.4      Relative Standard Deviation = 13.9% 
 
 
 
Tables 14 and 15 are the results of the determination of cholesterol using the 
proposed FIA-POCL method.  The results are quite similar to that of the colorimetric 
procedure.  The smaller volume solutions of the samples gave higher cholesterol contents 
than using greater volumes of the prepared sample.  This again points to the faulty 
pipetting volumes.  However, in general it seems the proposed method gave a larger 
cholesterol contents in these food items than the colorimetric method.  For instance the 
mean for the butter sample obtained by the proposed FIA-POCL method was 11.4 mg 
cholesterol/g sample while the colorimetric method gave 11.0 mg cholesterol/g sample.  
The variation for the cheeses were greater with the proposed method gave consistently 
higher values. 
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Table 15.   Results of the Proposed FIA-POCL Method Determination of Cholesterol in 
      Cheeses 
 
 
Cheese Type 
(µL sample) 
CL 
Intensity 
Cholesterol  
Found (mg/mL) 
Cholesterol 
Found (mg) 
Cholesterol 
Found (mg/g) 
Italian     
500 0.120 0.0141 0.0707 14.14 
500 0.139 0.0154 0.0772 15.44 
1000 0.273 0.0247 0.1233 12.33 
1000 0.280 0.0251 0.257 12.57 
  Mean (RSD) 13.62 (10.68%)  
Cheddar     
500 0.120 0.0141 0.0707 14.13 
500 0.120 0.0141 0.0707 14.13 
1000 0.263 0.239 0.1199 11.99 
1000 0.280 0.0251 0.1257 12.57 
  Mean (RSD) 13.21 (8.32%)  
Harvati     
500 0.130 0.0148 0.0741 14.82 
500 0.130 0.0148 0.0741 14.82 
1000 0.273 0.0246 0.1233 12.33 
1000 0.270 0.0244 0.1233 12.23 
  Mean (RSD) 13.55 (10.85%)  
 
 
 
The proposed FIA-POCL method was also extended to determine the cholesterol 
contents in lard, beef, and chicken fat.  The results of the determination are tabulated in 
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Table 16.  The values obtained for all three kinds of sample were quite consistent in 
range which is quite reassuring. 
Table 16.  Results of the Proposed FIA-POCL Method Determination of Cholesterol in 
     Beef and Chicken Fat and Lard 
 
 CL Intensity Cholesterol Found (mg) 
Cholesterol Found 
(mg/g fat) 
Beef fat in (µL)    
500 0.107 0.062 12.4 
 0.105 0.061 12.2 
 0.100 0.059 11.8 
1000 0.22 0.112 11.2 
 0.23 0.116 11.6 
 0.23 0.116 11.6 
Mean = 11.8 mg/g     Relative Standard Deviation = 3.8 % 
Chicken fat (µL)    
500 0.11 0.063 12.7 
 0.11 0.063 12.7 
 0.11 0.063 12.7 
1000 0.22 0.111 11.1 
 0.23 0.116 11.6 
 0.24 0.121 12.1 
Mean = 12.2 mg/g     Relative Standard Deviation = 5.6 % 
Lard (µL)    
500 0.1 0.059 11.8 
 0.11 0.059 11.8 
 0.11 0.059 11.8 
1000 0.22 0.112 11.2 
 0.23 0.116 11.6 
Mean = 11.6 mg/g     Relative Standard Deviation = 2.0 % 
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CHAPTER 6 
SUMMARY AND CONCLUSION 
The proposed enzymatic CL procedure for the determination of free cholesterol 
was evaluated in terms of its precision, linearity, and accuracy.  The experimental 
procedures once optimized, and based on the results shown in Chapter five the feasibility 
of the proposed FIA-POCL method for the determination total cholesterol in different 
food samples was feasible. 
The linearity studies indicated that the proposed FIA-POCL procedure has a good 
dynamic range.  The calibration curve for hydrogen peroxide had an equation of              
y = 13886.42x + 21.60 for hydrogen peroxide concentrations from 9.0 x10-4 M to          
4.4 x 10-3M.  For standard cholesterol, calibration curve had a regression equation of        
y = 15.29x – 0.04 of correlation coefficient 1.00.  The reproducibility of the proposed 
procedure was established by two different experiments.  The study using standard 
cholesterol solution at a concentration of 0.020 mg/mL gave a relative standard deviation 
of 2.57% and the second set using English butter of 0.20 mg/mL gave a relative standard 
deviation of 2.11 %.  The accuracy of the proposed study was examined using 
commercial standard cholesterol and the store butter sample.  The recoveries found using 
the commercial cholesterol standard were from 97.5 to 103.3 % and that of the butter 
samples were from 101.5 to 108.0 %.  Clearly, the proposed FIA-POCL method has 
figures of merits which are satisfactory. 
  The proposed method were applied to determined the total cholesterol in food 
items such as butter, cheese, lard and chicken and beef fat, which are considered to have 
high levels of  cholesterol.  For comparison, an enzymatic colorimetric method of 
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determination was run parallel with the proposed FIA-POCL for some of the food items.  
For the butter, cheese, and lard the results for the colorimetric method and the proposed 
procedure obtained were comparable.  The FIA-POCL method found the amount of total 
cholesterol and the relative standard deviation are in butter, 11.4 mg/g (13.9%), beef fat, 
11.8 mg/g (3.8%), chicken fat, 12.2 mg/g (5.6%), lard, 11.6 mg/g (2.0%), and in cheese, 
overall, 13.5% (10.0%).  However, the proposed FIA-POCL method gave results which 
were consistently higher than the colorimetric method.  The labels in all cheese and butter 
packages, regardless of brands and sources, all gave the same value, without stating it 
was free or total cholesterol.  The label values are about 10 times lower than the values 
obtained by the enzymatic colorimetric procedure and the proposed FIA-POCL method.  
However, the FIA-POCL in one set of experiment on reproducibility gave us an error 
+2.0% from the expected value using the standard cholesterol solution. So the labeled 
value seemed suspect. 
In conclusion, the proposed FIA-POCL method can be used for the determination 
of total and free cholesterol.  We should conduct further study to determine if the cause 
of some discrepancies was due to pipeting or pipet calibration.   Also, it may be better 
separation or extraction can be devised as comparison to the proposed method in which 
no extraction procedure was carried out.  
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